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I. Introduction
Polymer nanocomposites containing carbon nanopar-
ticles as nanofillers are next-generation smart materials.
As always, the researchers’ goal is to transfer as much
of the properties of the nanomaterials as possible from
the nano- to the macroscale. The discovery of the
buckminsterfullerene (C60) was made in 1985 by
R.Smalley, R.Curl and H.Kroto, who were awarded
the 1996 Nobel Prize in chemistry. The subsequent
years have seen a journey of discovery in the field of
nanoscience and nanotechnology, a journey that contin-
ues with the recent discovery of C60 ions in space.
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Since their discovery, fullerenes have become one of the most recognizable molecules in science. The ‘beautiful
molecule’ described by Harold W.Kroto has been subtly referenced in movie, and has adorned the covers of many
science-based textbooks. The physical and chemical properties of fullerenes have generated a lot of interest in the
science community with many opportunities to develop new avenues for scientific research. Difficulties in the
commercial use of fullerenes (e.g., C60) have likely been due to issues with solubility. Fortunately, the situation has
improved over the last decade with research into fullerene derivatives. Once modified, fullerenes may have applications
in a variety of areas including medicine, drug delivery, optoelectronics and electrochemistry. The addition of low
concentrations of carbon nanoparticles to polymer matrices may result in significant changes in the function of
polymer-based composite materials. This review will highlight the applications of fullerene derivatives as nano-
additives for polymer composites. Various fullerene derivatives, viz., water-soluble carbon nanoclusters modified with
hydroxyl and carboxyl groups, as well as hydrophobic fullerenes (metallofullerenes and methanofullerenes) will be
evaluated in regard to their potential impact on commercial applications, in particular, photovoltaic devices, fuel cells,
membrane technology and biocompatible electroactive actuators. We, members of Harold W Kroto’s research group
in Florida and international collaborators, miss his exuberance and passion for engaging with young researchers, and
we stand committed to preserving his legacy of science and outreach.
The bibliography includes 387 references.
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The inherent properties of fullerenes have been
investigated for potential use in some applications
including light-activated antimicrobial agents, heat-
resistant materials, superconductivity and biocompati-
bility in the field of medicine. Fullerenes have been used
in photovoltaic devices,1 biomedical devices,2 fuel cells 3
and membrane processes.4 – 11 Incorporating fullerenes
into polymer matrices has been shown to improve the
physical and transport properties of the host poly-
mers.12, 13
Fullerenes are typically produced by arc or combus-
tion methods and subsequent purification of reaction
products. The resulting fullerenes can then be mixed
with polymers. However, the poor adhesion and low
miscibility of fullerenes with conventional organic sol-
vents typically prevent them from being well-dispersed
in polymer matrices. To overcome these difficulties,
fullerenes can be functionalized with hydrophilic and
hydrophobic groups, which enhance their physicochem-
ical properties and promote their dispersion and strong
adherence in polymer matrices. Fullerene derivatives
have improved miscibility with host polymers without
significant agglomeration, an essential characteristic for
a wide range of applications.
In this review, a number of fullerene derivatives will
be highlighted, including water-soluble fullerene deriva-
tives (polyhydroxylated fullerenes, carboxyfullerenes
and malonic acid derivatives) and hydrophobic fuller-
enes (metallofullerenes and methanofullerenes).
A survey of publications related to fullerene deriva-
tives in the past 30 years is shown in Fig. 1.
First of all, Fig. 1 highlights a trend of increasing
focus on fullerene derivatives over the last 30 years.
This led to the creation of hybrid materials composed of
polymer matrices and carbon additives. Pioneering pub-
lications on polymer nanocomposites appeared in the
early 1990s. Over 4000 publications on polymer-carbon
nanoparticles have been reported to date.
Water-soluble fullerene derivatives have been consid-
ered for applications in biology and medicine. In partic-
ular, hydrophilic fullerene derivatives can be used as
antioxidants and help to prevent biological structures
from the action of reactive oxygen species (ROS). A
recent review on the physicochemical properties and
A.V.Penkova. Candidate of Chemical Sciences, Associate Professor at the
Institute of Chemistry, SPbSU.
Telephone: +7 (812) 428 – 4805, e-mail: a.penkova@spbu.ru
Current research interests: membranes, polymers, polymer nanocompo-
sites.
S.F.A.Acquah. Associate Research Professor of Chemistry, Department
of Chemistry and Biochemistry, Florida State University (USA), Director
of the H.W.Kroto Legacy Research Group and Director of Global
Educational Outreach for Science, Engineering and Technology
(GEOSET) Programme at the same University.
Telephone: +1 (850) 320 – 4686, e-mail: sacquah@chem.fsu.edu
Current research interests: carbon nanoparticles (carbon nanotubes,
fullerenes, etc.), nanotechnology, polymer nanocomposites, solar cells.
L.B.Piotrovskiy. Doctor of Biological Sciences, Professor, Head of the
Laboratory of Drug Synthesis and Nanotechnology, IEM.
Telephone: +7 (812) 234 – 6868, e-mail: levon-piotrovsky@yandex.ru
Current research interests: drug design, carbon nanostructures.
D.A.Markelov. Doctor of Physical and Mathematical Sciences, Associate
Professor of Faculty of Physics, SPbSU, Researcher at the ITMO
University.
Telephone: +7 (812) 428 – 9948, e-mail: markeloved@gmail.com
Current research interests: polymers, nanoparticles, membranes,
modelling, molecular dynamics simulation, NMR.
A.S.Semisalova. Candidate of Physical and Mathematical Sciences,
Assistant Professor of Department of Physics at the MSU, Postdoctoral
Researcher of the Institute of Ion Beam Physics and Materials Research,
Helmholtz-Zentrum Dresden –Rossendorf (Germany).
Telephone: +7 (495) 939 – 1847, e-mail: semisalova@magn.ru
Current research interests: magnetic materials, smart magnetorheological
elastomers, nanoparticles.
H.W.Kroto. Eppes Professor of Chemistry, Florida State University
(USA), 1996 Nobel Prize laureate in chemistry (deceased in 2016).
Received 24 November 2016
1985 – 1990 1991 – 1995 1996 – 2000 2001 – 2005 2006 – 2010 2011 – 2016 Years
fullerenol
carboxylic fullerene
metallofullerene
PCBM
N
u
m
b
er
o
f
p
u
b
li
ca
ti
o
n
s
Figure 1. Comparison of the annual number of scientific publications devoted to fullerene derivatives in the past 30 years.
Data analysis of publications was performed using the Scopus database with the terms ‘PCBM’, ‘fullerenol’, ‘carboxylic fullerene’, and
‘metallofullerenes’ as of the 28th August 2016.
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applications of fullerenols, promising pharmaceutical
additives for the treatment of oxidative stress-related
diseases, is available.14 Fullerenols can also be used in
biocompatible actuators as part of electroactive artifi-
cial muscles. Fullerenols and carboxyfullerenes can be
incorporated into chemosensors and biosensors. The
application of fullerenols in membrane technology
leads to improvement in the properties of diffusive
pervaporation membranes and the conductivity in fuel
cells, especially at low relative humidity (RH). Full-
erenols have demonstrated the potential for application
in photocatalysis and photovoltaic devices. They show
excellent optical transmission and electron transporting
properties. For example, the surface morphology and
wettability of fullerenol thin films on indium tin oxide-
coated glass could be tuned by simply changing the
annealing temperature; this causes changes in the photo-
voltaic performance of the inverted devices with full-
erenol as a cathode buffer layer.15
Hydrophobic fullerene derivatives, metallofullerenes
and methanofullerenes are being investigated in regard
to application in sensors and photovoltaic devices. A
poly(3-hexylthiophene) : [6,6]-phenyl-C61-butyric acid
methyl ester (P3HT: PCBM) composite is a promising
active layer material for photovoltaic solar cells (PSCs)
with power conversion efficiencies (PCE) approaching
5% – 6%. Metallofullerenes demonstrate good potential
for applications in catalysis.
Despite the broad use of polymer composites with
carbon additives, the annual number of papers did not
significantly change from 2005 to 2016 (except publica-
tions on polymer – PCBM composites whose number has
been increasing dramatically over the last years). The
groundbreaking experiments on graphene by A.Geim
and K.Novoselov, which resulted in the 2010 Nobel
Prize in physics, provide a renewed perspective on the
application of carbon nanoparticles and nanoscience in
general.
In the forthcoming Sections, the progress towards
the development of fullerene derivatives as nano-addi-
tives in polymer composites will be reviewed, with
applications of polymer nanocomposites in biology,
medicine, physics, chemistry, engineering and material
science.
Notations used in the review are as follows:
AFM — atomic force microscopy
ATP — adenosine 5 0-triphosphate
BHJ — bulk heterojunction
BSA — bovine serum albumin
DDAB — didodecyldimethylammonium bromide
DIO — 1,8-diiodooctane
DOP — dioctyl phthalate
DOTA — 1,4,7,10-tetraazacyclododecane-1,4,7,10-
tetraacetic acid
dPCBA — 3,4-dihexyloxyphenyl-C61-butyric-acid
DTPA — diethylenetriaminepentaacetic acid
EMF — endohedral metallofullerene
EQE — external quantum efficiency
FF — fill factor
HSA — human serum albumin
HOMO — highest occupied molecular orbital
IPMC — ionic polymer metal composite
JSC — short circuit current
LUMO — lowest unoccupied molecular orbital
MEH-PPV — poly{2-methoxy-5-(20-ethylhexyloxy)-
1,4-phenylenevinylene}
MIP — molecularly imprinted polymer
MRI — magnetic resonance imaging
P3HT — poly(3-hexylthiophene)
P3OT — poly(3-octylthiophene)
PCBM — [6,6]-phenyl-C61-butyric acid methyl ester
PC70BM — [6,6]-phenyl-C71-butyric acid methyl
ester
PC84BM — [6,6]-phenyl-C85-butyric acid methyl
ester
PCDTBT — poly[N-900-heptadecanyl-2,7-carbazole-
alt-5,5-(40,70-di-2-thienyl-20,10,30-benzothiadiazole)
PCE — power conversion efficiency
PEG — polyethylene glycol;
PEM — polymer electrolyte membrane
PSC — photovoltaic solar cell
PSVPy — poly(styrene-co-4-vinylpyridine)
PTB4 — poly({4,8-bis(n-octyloxy)-benzo[1,2-
b:4,5-b0]dithiophene-2,6-diyl}{3-fluoro-2-[(2-ethylhexyl)-
carbonyl]thieno[3,4-b]thiophenediyl});
PTB7 — poly({4,8-bis[(2-ethylhexyl)oxy]benzo[1,2-
b:4,5-b0]dithiophene-2,6-diyl}{3-fluoro-2-[(2-ethylhexyl)-
carbonyl]thieno[3,4-b]thiophenediyl});
PUE — polyurethane elastomer
PVA — polyvinyl alcohol
PVP — polyvinylpyrrolidone
ROS — reactive oxygen species
SPEI — sulfonated poly(ether imide)
TEM — transmission electron microscopy
ThCBM — [6,6]-thienyl-C61-butyric acid methyl ester
TNT-EMF — trimetallic nitride template endohedral
metallofullerene
UV — ultraviolet
VOC — open circuit voltage
II. The structure of carbon nano-additives
Among covalent fullerene derivatives, mention should
be made of the widely used polyhydroxylated fullerenes
(so-called fullerenols) .
Polyhydroxylated fullerenes are fullerene derivatives
containing different numbers of hydroxyl groups. After
the synthesis, a fullerenol is a complex radical anion of
the general formula Nan [C60Ox(OH)y]n7 rather than
simply polyhydroxylated C60 molecule.16 Figure 2
O
H
C
Figure 2. Molecular structure of fullerenol.
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presents the molecular structure of fullerenol.17 The
formula C60(OH)n corresponds to the structure averaged
over a mixture of fullerenols bearing different number
of hydroxyl groups, each with its own regioisomers. The
solubility of fullerenols depends on the number of
hydroxyl groups.
Endohedral metallofullerenes (EMFs) are produced
by encapsulating a metal atom (Li, Ca, Sr, Ba, Ti, U,
Zr, Hf, Sc, La and other lanthanide atoms, etc.) or
metal clusters within the fullerene cage. These systems
are classified by their inner composition and the size of
the carbon cage. Mono- and dimetallofullerenes (e.g.,
La@C82 and LaR2R@C80) have been successfully syn-
thesized, as well as complexes of fullerenes with metal
nitrides (e.g., Sc3N@C2n) and more complex species,
namely, encapsulated metal carbides (MnC2 , n=2 – 4),
hydrogenated metal carbides (Sc3CH), metal nitrogen
carbides (MxNC, x=1, 3), metal oxides (ScyOz , y=2,
4; z=1 – 3) and metal sulfides (M2S).18
Endohedral metallofullerenes are a new class of
compounds combining nanotechnology with organic
and inorganic chemistry. Due to unique electronic
structure, they have found wide application in various
fields. The properties of metallofullerenes are com-
pletely different from those of pure fullerene, partially
because the interaction between the encapsulated metal
atom or cation and fullerene leads to emergence of
unique electronic properties. The intrinsic charge trans-
fer from the encapsulated metal atom(s) to the carbon
cage, which was predicted theoretically and observed
experimentally, can stabilize the fullerenes whose struc-
ture does not obey the isolated pentagon rule. The
structures of some EMFs are presented in Fig. 3.19
Methanofullerenes are fullerenes with a methano
bridge (a bond between two six-membered rings; it is
present in all the reported methanofullerenes). Figure 4
presents the structures of methanofullerenes that are
most widely used as electron acceptors, viz., [6,6]-phe-
nyl-C61-butyric acid methyl ester (PCBM), [6,6]-phenyl-
C71-butyric acid methyl ester (PC70BM) and [6,6]-
thienyl-C61-butyric acid methyl ester (ThCBM).
Carboxyfullerenes are fullerenes functionalized with
carboxyl groups and having a methano bridge. A typical
example of a carboxyfullerene is (1,2-methanofullerene-
C60)-61-carboxylic acid (Fig. 5).
III. The applications of fullerene derivatives
III.1. Photovoltaic devices and photocatalysts
The unique combination of physical and chemical prop-
erties of carbon nanomaterials including fullerenes has
stimulated advanced research in many areas of applied
a b c
Figure 3. Molecular structures of EMFs containing encapsulated trimetallic nitride Tm3N@Ih-C80 (a), metal carbide Gd2C2@D3(85)-C92
(b) and a metal oxide cluster Sc4(m3-O)2@Ih-C80 (c).19
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Figure 4. Molecular structures of methanofullerenes PCBM (a),
PC70BM (b) and ThCBM (c).
HO O
Figure 5. Molecular structure of
(1,2-methanofullerene-C60)-61-ca-
rboxylic acid.
A.V.Penkova, S.F.A.Acquah, L.B.Piotrovskiy, D.A.Markelov, A.S.Semisalova, H.W.Kroto
Russ. Chem. Rev., 2017, 86 (6) 530 – 566 533
science.20 – 26 One of the most promising areas of
research into fullerene derivative is photovoltaics.27, 28
The sun delivers 1368 Wm72 (so-called solar constant)
to our planet. After reflection and absorption by the
atmosphere, this value decreases to 198 Wm72.29 About
40% of solar radiation is visible light, 10% is UV, and
50% is IR radiation. In total, the yearly solar energy
that reaches the planet is approximately 6200 times
more than the world’s energy consumption in 2008 and
4200 times more than the energy that is expected to be
demanded by humankind in 2035 (following the IEA’s
Current Policies Scenario 30).
Thus, it takes about 1.5 h for the Sun to cover the
year’s primary consumption of energy.31 This fact
makes the Sun the largest energy resource on the planet
and explains the colossal scientific and technological
interest in solar energy. Photovoltaic devices offer an
opportunity to convert the solar energy into electricity
and electric power.
Organic photovoltaics is considered a very promising
technology due to several key advantages, in particular,
light weight and flexibility. The low cost of material
components and peculiarities of the production process
allow easy fabrication of large-area solar cells.32 – 34
Fullerenes are characterized by high electron affinities
and thus belong to the most important components of
organic solar cells. A comparison of third-generation
solar cells including organic photovoltaic devices can be
found in a detailed review.27
III.1.a. Basics of solar cells
Photoinduced charge transfer to fullerenes was for the
first time demonstrated in 1992.35 This was followed by
a report about the first photovoltaic cell based on a
heterojunction between the semiconducting polymer
MEH-PPV (donor) and C60 acting as an acceptor.36
Following the method introduced in Ref. 35, charge
transfer from the conjugated polymer MEH-PPV to
fullerene can be described within five steps:
excitation of donor
D+A D*+A
delocalization of excitation on the D – A complex
D*+A (D7A)*
initiation of charge transfer
(D7A)* (Dd+7Ad7)*
formation of radical ion pair
(Dd+7Ad7)* (D+.7A7.)
charge separation
(D+
.7A7.) D+.+A7.
the process of electrical current generation in organic
solar cells is schematically shown in Fig. 6.27, 37
Light absorption in organic solar cells is followed by
generation of excitons (bound electron – hole pairs).
Their dissociation into two charged counterparts at
interfaces between materials with different electron
affinities leads to energy conversion. Such dissociation
can also be guided by an electric field.
The efficiency of the original bilayer fullerene-based
solar cells was limited by the low surface area of
heterojunctions. This problem was resolved using full-
erene derivatives.38 The chemically improved solubility
of C60 in organic solvents was achieved in its modified
form, PCBM. This allowed for the creation of a bulk
heterojunction (BHJ)-based solar cells where the semi-
conducting polymer (donor) and fullerene derivative
(acceptor) were intermixed, thus providing a larger
interfacial area than in the initial bilayer structure. A
typical architecture of a BHJ solar cell includes a
solvent-cast p-conjugated polymer/fullerene derivative
blend film sandwiched between electrodes.39
There are many donor polymers currently used for
BHJ solar cells.40, 41 Early reports demonstrated high
efficiency of bulk heterojunctions. In particular, it was
reported that the PCE of solar cells based on a MEH-
PPV – PCBM blend is equal to 2.9% and can be further
increased to 5.5%.42 The enhanced efficiency of up to
4.5% – 5% for P3HT:PCBM solar cells was achieved
through careful control of the growth and morphology
of the active layer, reduction of the free volume and the
number of trapping sites, as well as improvement of the
interfaces and the quality of the contact with electro-
des.43, 44
Solar cells based on poly({4,8-bis(n-octyloxy)-ben-
zo[1,2-b:4,5-b0]dithiophene-2,6-diyl}{3-fluoro-2-[(2-ethyl-
hexyl)carbonyl]thieno[3,4-b]thiophenediyl}) (PTB4)/
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Figure 6. Diagram of the fundamental process of energy conversion.27
Light absorption and exciton generation (1); diffusion of excitons (2); electron transfer from excited donor to acceptor at the donor-
acceptor interface (DEDA is the LUMO energy difference between the donor and acceptor, or the donor/acceptor LUMO offset) (3 );
negative charge carriers in the acceptor and positive charge carriers in the donor diffuse and/or drift by hopping to neighbouring molecules
(4); and collection of charges at the electrodes and subsequent transfer to the external circuit (5).
Electrons and holes are denoted as e7 and h+, respectively.
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PCBM have a PCE of up to 6.1%; here, the newly
developed polymer with higher hole mobility and mis-
cibility was used to achieve better interpenetration with
the fullerene derivative.45 The electrical properties of
fullerene derivatives and their influence on the photo-
voltaic performance have been studied.46 – 48 Com-
pounds PC70BM and ThCBM are also often used as
acceptors in photovoltaic devices.28, 49
Limitations on the efficiency of PCBM-based solar
cell were studied 50 using poly({4,8-bis[(2-ethylhexyl)-
oxy]benzo[1,2-b:4,5-b0]dithiophene-2,6-diyl}{3-fluoro-2-[(2-ethyl-
hexyl)carbonyl]thieno[3,4-b]thiophenediyl}) (PTB7) as
donor polymer. It was shown that the main factor
influencing the device performance is the relatively
poor electron mobility due to inefficient formation of
the PCBM network within the blend. The microstruc-
ture of polymer – fullerene derivative blends was studied
using energy-filtered transmission electron microscopy
(TEM) and photoluminescence quenching. It was pro-
posed to tune the PCBM phase connectivity for a
significant increase in the solar cell efficiency without
improving the hole mobility in the polymer. Also, the
role of the solvent additive (1,8-diiodooctane, DIO) was
investigated and it was shown that DIO reduces the
geminate recombination probability.
Currently, PCBM-based solar cells are still consid-
ered among the most efficient ones. The well-known
advantage of PCBM is good solubility in many organic
solvents. However, weak absorption of PCBM in the
visible region 21 due to high symmetry of the molecule,
which makes the lowest-energy transitions formally
dipole forbidden, motivates further development of full-
erene derivatives, which could absorb solar energy more
effectively.
A higher fullerene analogue of PCBM based on C70,
PC70BM (see Fig. 4 b), exhibits enhanced light absorp-
tion in the visible region.51 Solar cells based on PC70BM
provide more effective light absorption in the UV and
visible regions compared to the PCBM-based cells and a
PCE improvement up to 10%. Liang et al.52 compared
the efficiency of solar cells using a donor polymer based
on alternating thieno[3,4-b]thiophene and benzodithio-
phene units (PTB1) and PCBM and PC70BM as accept-
ors. The device based on the higher fullerene derivative
demonstrated enhanced external quantum efficiency
(EQE) in the wavelength range from 400 to 750 nm,
with a maximum of 67% at 650 nm. For the PCBM-
based solar cell, the maximum EQE was *60% at the
same wavelength. The corresponding PCE values were
5.6% and 4.76%, which confirms the significant role of
PC70BM in the improvement of the solar cell perform-
ance without additional engineering treatment.
A PCE of 6.1% was reported for PCDTBT : PC70BM
solar cells.53 An extremely high internal quantum effi-
ciency almost corresponding to ‘one absorbed elect-
ron – one pair of charge carriers’ was achieved through
the optimized ratio of the polymer and PC70BM.53
The difference in the shape of PCBM and PC70BM
molecules (sphere vs. ellipsoid with an aspect ratio of
the fullerene moiety of 1.14) 54 leads to a discrepancy in
the molecular packing of these fullerene derivatives and
consequently to different, orientation-dependent inter-
molecular electronic coupling. Molecular dynamics sim-
ulations revealed an apparent difference in the
formation of a layer of the nearest neighbours including
their distribution, the number of molecules in the shell
and the distance to the neighbouring molecules. All
these parameters specify the electronic coupling and
properties of fullerene aggregates.
The stability of photovoltaic devices based on
PTB7:PC70BM and possible ways to protect the solar
cell against degradation and to increase its lifetime using
additional optically active layers were explored.55 The
influence of the molecular mass (Mn) of polymer and the
solvent additive (1-chloronaphthalene, CN) on the per-
formance efficiency of a PC70BM-based solar cell was
studied 56 using poly[di(2-ethylhexyloxy)benzo[1,2-b:4,5-b0]-
dithiophene-co-octylthieno[3,4-c]pyrrole-4,6-dione] (PBDTTPD)
as donor polymer. It was found that low molecular mass
of PBDTTPD resulted in poor efficiency mostly because
of the phase separation of the polymer and fullerene
derivative and the formation of PC70BM-enriched
domains, which was avoided in the case of the high-Mn
polymer. That study 56 and several similar publica-
tions 57, 58 have demonstrated that the correlation
between the BHJ solar cell performance and the molec-
ular mass of the donor polymer may appear to be a
promising method for optimization of the solar cell
morphology and design of highly efficient structures.
Enhanced performance of a photovoltaic device can
be achieved using solvent additives.59, 60 A study of a
solar cell based on PTB7:PC70BM with the DIO and
1,8-dibromooctane additives revealed an increase of
almost 150% in PCE (from 2.74% to 6.76%) in compar-
ison with the initial devices fabricated without addi-
tives.61 Improved charge transport and charge collection
efficiency, as well as more effective light absorption in
the blended solar cell with additives are the main factors
responsible for the PCE enhancement.62 Formic acid
(FA) was also suggested 63 as a novel additive to
improve the performance of a PTB7:PC70BM solar cell
and to increase the short circuit current JSC. A signifi-
cant increase in JSC from 14.57 to 24.11 mA cm72 upon
the addition of FA was attributed to enhanced charge
carrier mobility, enhanced light absorption and more
effective exciton generation.
High PCE values have recently been reported for
photovoltaic devices based on PC70BM and new molec-
ular donors. Sun et al.64 presented a benzodithiophene
terthiophene rhodanine (BTR) with ben-
zo[1,2-b:4,5-b0]dithiophene core and rhodanine periph-
eral moieties as a new thermally stable material for roll-
to-roll techniques in large-scale production of organic
solar cells. Photovoltaic devices based on BTR:PC70BM
demonstrated an efficiency of up to 9.3% with a fill
factor (FF) of 77%. Strong intramolecular interactions
in BTR, which determine the liquid-crystalline proper-
ties of the material, also provide very high hole mobi-
lity, resulting in the record high value of PCE.
Another example of outstanding efficiency of
PC70BM-based solar cells was shown by He et al.65
They used a newly synthesized, narrow-band-gap semi-
conducting polymer poly{[2,60-4,8-di(5-ethylhexylthie-
nyl)benzo[1,2-b;3,3-b]dithiophene][3-fluoro-2[(2-ethyl-
hexyl)carbonyl]thieno[3,4-b]thiophenediyl]} (PTB7-Th).
Compared to PTB7, PTB7-Th has a narrow band gap
of 1.59 eV and its highest occupied molecular orbital
(HOMO) level lies 0.07 eV deeper (at 75.22 eV); also,
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the new polymer strongly absorbs between 500 and
800 nm. These results looked very promising, and the
expectation of better performance of the new donor in
combination with PC70BM was confirmed experimen-
tally. The parameters of the fabricated device were
VOC= 0.815 V, JSC= 17.52 mA cm72, FF= 72% and
PCE= 10.28%.
Since the same research group earlier reported an
efficiency of 9.15% for a PTB7-PC70BM solar cell,66 the
success of tuning VOC and photocurrent in the PC70BM-
based device by deepening the lowest unoccupied molec-
ular orbital ( LUMO) level and narrowing the polymer
band gap was justified. A recent study 67 showed that
long-term photostability of organic solar cells based on
PTB7-Th can be improved by removing the residual
solvent (DIO) required to cast the polymer – fullerene
blend film.
Highly efficient BHJ solar cells based on a mixture
of PTB7 and PC70BM dissolved in o-xylene were
reported.68 The possibility of designing solar cells using
non-chlorinated and, therefore, less toxic solvents (e.g.,
xylene) is of high priority in the development of photo-
voltaic devices for common consumption.69
There are reports on interesting ways to use fullerene
as a dopant in the active layers of photovoltaic devices.
For instance, an impressive improvement of the PCE of
an inverted PTB7-Th:PC70BM polymer solar cell from
7.64% up to 9.35% was achieved when the ZnO cathode
was modified with [6,6]-phenyl-C61-butyric acid hydrox-
yethyl ester (PCBE-OH).70 The modified ZnO – C60
cathode enhances the electron collection and electronic
conductivity at the interface and in the bulk of the
cathode.
The further increase in the size of fullerene deriva-
tives entailed the synthesis of PC84BM.71 In spite of
more efficient light absorption (extended to near-IR
region) and electron mobility observed in C84,27, 72 this
fullerene derivative has not found practical application
in the BHJ solar cells due to low solubility, weak
photocurrent and increased recombination of charge
carriers.71 A comparison of the absorption spectra of
three methanofullerenes is presented in Fig. 7. Recently,
the role of PC84BM impurities in the polymer BHJ solar
cells was explored in charge trapping and trap-assisted
recombination.73, 74 The Shockley – Read – Hall recombi-
nation from inorganic material (through a single defect
state in the energy gap) was shown to be significantly
affected by PC84BM traps in the active layer of the solar
cell. Experiments with BHJ solar cells composed of a
copolymer of PCDTBT with PCBM showed that all
characteristics of the photovoltaic devices decreased
upon the addition of PC84BM. Femtosecond transient
absorption spectroscopy measurements were performed
to study the decay dynamics of polarons. Measurements
revealed increased polaron trapping and trap-induced
recombination. This conclusion was confirmed in a
more recent study 75 where the photophysical processes
associated with impurities were analyzed and compared
with the results obtained upon doping with PC84BM and
7,7,8,8-teracyanoquinodimethane (TCNQ).
The PCBM-like thienyl-containing fullerene deriva-
tive ThCBM (see Fig. 4 c) was developed for better
polymer-to-fullerene conformity in photovoltaic devi-
ces.76
A higher efficiency of organic photovoltaic cells can
be obtained by increasing JSC and VOC. The modifica-
tion of active layers in photovoltaic devices was success-
fully used for developing short circuit current.77, 78 In
particular, the increase in JSC can be reached by
enhancing the optical absorption upon symmetry reduc-
tion of the fullerene core.79
The VOC value of a solar cell depends on the energy
difference between the donor HOMO and the acceptor
LUMO.80 – 82 For efficient exciton dissociation and elec-
tron transfer from donor to acceptor, the LUMO of the
donor should lie 0.3 – 0.5 eV higher than that of the
acceptor.83, 84 In a typical organic photovoltaic cell
based on regioregular P3HT and PCBM, this energy
difference is 1.17 eV, which is much higher than the
desirable value and, consequently, leads to a suppres-
sion of VOC . The difference between the LUMO ener-
gies can be decreased by lowering the donor LUMO 85
or by raising the acceptor LUMO,86 both ways being
theoretically promising.87 In the former case, the photo-
current increases due to enhanced overlapping between
the donor absorption spectrum and the solar spec-
trum.88 In the latter case, VOC increases directly since
it is proportional to the energy difference between the
fullerene LUMO and the polymer HOMO.
The further optimization of fullerene derivatives was
proposed in a series of reports 89 – 94 where the bisadduct
analogues of PCBM, ThCBM and other fullerene deriv-
atives were introduced as new fullerene-based high-
LUMO semiconductors for organic photovoltaics
(Fig. 8). Since the synthesis of PCBM-like fullerene
derivatives affords a mixture of mono- and multiad-
ducts, the desired fractions can be separated by column
chromatography.
In an early study, an increase of up to 100 meV
(corresponds to 73.7 eV) in the LUMO level of bis-
PCBM was reported. Compared to the P3HT:PCBM
solar cell, the PCE increased by almost 20% up to
4.5% due to VOC enhancement. Higher fullerene adducts
were experimentally studied using photovoltaic cells
based on P3HT as donor.90 Despite relatively high VOC
values obtained by shifting the LUMO level, the PCE
was found to be the same as that of the PCBM-based
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Figure 7. Absorption spectra of various methanofullerenes.27
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solar cell or even lower. This was explained by the
reduced electron mobility and lower JSC in the devices
based on the bisadducts.
Later, Liu et al.95 tested the influence of bis-PCBM
substitution on the stability and performance of
P3HT:PCBM solar cells and found that this bisadduct
can be successfully used as an inhibitor of phase sepa-
ration, providing high miscibility of the fullerene deriv-
ative and the polymer. The PCE of the device based on
bis-PCBM was surprisingly stable against thermal age-
ing (150 8C at 15 h).
Polymer solar cells based on PBDTBDD:bis-PCBM
with an efficiency of 6.07% were studied.96 The opti-
mized mass ratio of the polymer and fullerene deriva-
tive, as well as treatment with DIO were the key factors
in reaching high values of PCE, VOC (1.00 V), JSC (10.02
mA cm72) and a fill factor of 60.54% through the
efficient exciton dissociation and charge separation.
A detailed comparison of solar cells based on differ-
ent fullerene derivatives including bis-PCBM and
PC70BM using neutron reflectivity experiments was
performed by Chen et al. 97 The main parameter
addressed in this study was the miscibility of different
acceptors and its influence on the morphology of photo-
voltaic devices. It was shown that, depending on the
miscibility of fullerene, the size of domains and inter-
facial area in the blended films based on bis-PCBM
affect the resulting exciton dissociation and charge
transport, being the limiting factors for the photovoltaic
device performance. Chen et al. 97 also determined the
surface-to-surface distance between adjacent fullerene
derivatives that was considered sufficient for the recom-
bination process. Earlier, a comparison of parameters of
solar cells based on PC70BM- and bis-PC70BM and the
influence of intercalation in the case of poly{2,5-bis(3-
hexadecylthiophen-2-yl)thieno[3,2-b]thiophene} (pBTTT)
was reported.98
Methanofullerenes ThCBM and bis-ThCBM were
introduced as acceptors for solar cells based on
P3HT.99 The efficiency of the ThCBM-based devices
was comparable with that of PCBM-based ones (3.97%
vs. 4.18%, respectively), whereas the maximal efficiency
of the device based on bis-ThCBM was only 1.72% in
spite of higher VOC provided with the raised LUMO
energy level.
A review of the state of the art in application of
fullerene bisadducts is available.100
Vandewal et al.101 suggested to increase the VOC of
polymer-fullerene solar cells by controlling the spectral
position of the charge-transfer band 102 and changing
the electronic coupling between donor and acceptor
materials; the latter was demonstrated by Thompson
and co-workers.103 Using PCBM and PC70BM-based
solar cells, Vandewal et al.101 revealed a correlation
between electroluminescence and the photovoltaic EQE
spectra in the charge-transfer region, which opens an
additional pathway to tune the generated VOC .
To find an alternative way to reach a higher PCE is a
challenging task, which can be solved by increasing the
fill factor. Inverted BHJ solar cells based on PC70BM
and new in-chain donor – acceptor polymers with close
p7p-stacking demonstrated a fill factor up to 80%.104
A relatively new approach to achieve higher electron
mobility and PCE is to prepare hybrid inorganic-organic
nanocomposites containing metal nanoparticles and
nanowires. Enhanced functionality achieved through an
increase in electron mobility was reported for the hybrid
materials composed of gold nanowires and ThCBM
(Fig. 9).105
OMe
O
OMe
O
a b
OMe
O
OMe
O
OMe
O
S
O
OMe
S
OMe
O
S
O
OMe
S
c d
Figure 8. Fullerene bisadducts: bis-PCBM (a), bis-PC70BM (b),
bis-ThCBM (c) and bis-ThC70BM (d ).90
OO
OMe
MeO
S
S
A
u(
11
1)
Figure 9. Hybrid nanocomposite composed of Au nanowire and
ThCBM (n-type semiconductor).105
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Semiconducting molecular nanowires (in particular,
MoSI) were used to improve the P3HT:PCBM solar cell
efficiency.106 Increased hole mobility and good trans-
port properties of nanowires resulted in 52% enhance-
ment of PCE. Moreover, it was found that adding MoSI
nanowires on top of the active layer extends the absorp-
tion spectrum of the active layer, thus providing an
additional way to tune the conversion of photons to
electric current.
Semiconducting single-walled nanotubes (SWNT)
were shown to be promising additives for use in organic
solar cells.107 Doping of a solar cell based on regiore-
gular P3HT and PCBM with semiconducting SWNT
resulted in not only enhanced hole mobility in the
fullerene-polymer blend, but also improved thermal
stability of the device.
Recently, Zhang et al. 108 demonstrated the spin
enhancement of organic BHJ PSC doped with spin 1/2
radicals. Recombination of polaron pairs appearing as a
result of the separation of excitons at donor/acceptor
interfaces can be effectively suppressed using a p-con-
jugated radical galvinoxyl (2,6-di-tert-butyl-4-[(3,5-
di-tert-butyl- 4-oxocyclohexa-2, 5-dien-1-ylidene)methyl]-
phenoxyl). Spin 1/2 radicals resonantly induced the
spin-flip process of electron acceptor via an exchange
mechanism, converting the polaron pair from spin sin-
glet to triplet and enhancing its separation into free
charges. The PCE of PCBM-based solar cells increased
by almost 340%, which clearly shows the benefits of this
approach. Remarkably, the enhancement of the photo-
voltaic performance was observed only for PCBM,
whereas neither bis-PCBM nor indene-C60 bisadduct
(ICBA) demonstrated a similar response to doping with
spin 1/2 radicals.
Efforts are now aimed at better understanding of the
process of charge separation and hopping type transport
in organic photovoltaic solar cells with a focus on the
electron spin dynamics.109 – 111 A BHJ is highly disor-
dered system where materials with different properties
are intermixed, and this affects the generation and
dynamics of charge-transfer states.112
Predominant formation of singlet charge-transfer
states was studied recently using electron paramagnetic
resonance (EPR).113, 114 The evolution of the EPR spec-
tra of polymer-fullerene blends based on P3HT,
PCDTBT, PTB7 and PCBM was followed using the
time-resolved technique. A correlation between the life-
time of the intermediate radical pairs and the delocali-
zation length of the hole along the polymer chains was
revealed. The effect might be due to a stronger Coulomb
interaction between separated charges, leading to the
stable state of the radical pair. Stabilization of such
pairs is an intermediate step in electron transfer medi-
ated by hopping between electron acceptors and forma-
tion of charge-separated states.115
The possibility of fullerene dimerization opens the
way of designing new types of acceptors for PSCs.116
Despite the fact that PCBM-based dimer containing
hydroxyl groups demonstrated lower photovoltaic
response,117 covalent aggregation of fullerenes can sig-
nificantly improve the final device efficiency.118 It was
shown 119 that a PSC based on P3HT and a PCBM
derivative with the dumbbell-shaped structure 120 has a
higher PCE (3.7%) compared to the PCBM-based device
(3.22%). Interestingly, the LUMO energy level of the
dimeric fullerene derivative remained nearly the same as
that of PCBM. The increase in efficiency was due to the
significant enhancement of JSC to 10.34 mA cm72 for
the solar cell based on the dumbbell-shaped dimer from
8.45 mA cm72 for a standard solar cell based on PCBM.
Morinaka et al.121 performed a detailed study on the
influence of (i) fullerene dimerization and (ii) structure
of the dumbbell-shaped fullerene C60 derivatives on the
solar cell efficiency. Two fullerenes linked at para- and
meta-position of the phenyl ring were synthesized and
the photovoltaic properties of the P3HT- and PTB7-
based solar cells were investigated. The authors demon-
strated an important role of the molecular structure of
the dimers in achieving high JSC and FF values and in
tuning the morphology of the active layer. A PCE of
6.14% was reported for the solar cell based on PTB7
(donor) and the para-linked dumbbell-shaped dimer
(acceptor), which is comparable with a PCE of 6.24%
obtained for PCBM.
Ongoing research activity and a better understanding
of the physics behind the performance control of poly-
mer solar cells has led to progress in the development
and design of highly efficient devices. Among them,
molecular solar cells 122, 123 and tandem (multiple junc-
tion) solar cells 124, 125 with efficiencies over 10% can be
specified. Great efforts are being undertaken to create
novel types of acceptors, viz., methanofullerene deriva-
tives 126, 127 and others.128 An extensive review of recent
progress in the field is available.129
III.1.b. Metallofullerenes
Trimetallic nitride template endohedral metallofullerenes
(TNT-EMFs). Endohedral metallofullerenes 130, 131 are
fullerene C60 derivatives with encapsulated metal
atoms. They look promising for photovoltaic applica-
tions since they are materials with the LUMO level
shifted closer to the HOMO level of the polymer acting
as donor.132 Good examples of metallofullerenes are
provided by the nitrides TNT-EMFs M3N@C80
(M=Sc, Y, Gd, Tb, Dy, Ho, Er, Tm, Lu) in which
the metal is bound.133, 134
There are several reports on TNT-EMFs used as
electron acceptors in polymer conjugates. The thermal
stability and photophysical properties of the
Sc3N@Ih-C80 and Y3N@Ih-C80 dyads blended with tri-
phenylamine (TPA), ferrocene (Fc), extended tetrathia-
fulvalene (exTTF) and phthalocyanine (Pc) have been
studied and compared with C60-based analogues by
Pinzon et al.135, 136 It was found that photoinduced
charge separated states have a longer lifetime in the
case of the Sc3N@Ih-C80 derivative.
A photoinduced electron-transfer reaction in the
Sc3N@C80-Fc donor-acceptor dyad 138 was reported.137
N-methyl-2-ferrocenyl[5,6]-Sc3N@Ih-C80-fulleropyrrolidine
was prepared by thermal reaction of Sc3N@Ih-C80 with
sarcosine and ferrocenecarboxaldehyde in a toluene/
o-dichlorobenzene (o-DCB) mixture. Cyclic voltammo-
grams revealed three one-electron reversible reduction
peaks at 71.14, 71.53 and 72.25 V. The radical ion
pair state was found to be more stable than that for an
analogous C607Fc derivative. Additionally, the charge-
separation and charge-recombination dynamics were
followed by time-resolved transient absorption spectro-
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scopy in order to demonstrate the potential of TNT-
EMFs in organic photovoltaics.
New metallofullerene derivatives M3N@PC80BM
(M=Y, Sc), analogues of PCBM, were synthesized
and studied 139 and their importance for BHJ solar
cells was demonstrated. The synthesis and electrochem-
ical properties of a large family of TNT-EMFs
M3N@C2n (M=Gd, Ce, Pr, Nd; 2n=80, 82, 84, 86,
88) were reported.140 The influence of the carbon cage
symmetry and size on the electrochemical properties of
fullerenes were investigated and it was concluded that
the LUMO is localized on the metallic cluster while the
HOMO is localized on the carbon cage. Due to the
intrinsic stability and unique properties of TNT-EMFs,
they can be considered as candidates for many applica-
tions besides photovoltaics, e.g., as contrast agents for
magnetic resonance imaging (MRI).
First synthesized by Ross et al.,86 Lu3N@C80 deriv-
atives revealed better performance in P3HT-based
organic solar cells as compared with an analogous
P3HT:PCBM-based device, namely, the higher LUMO
provided a higher VOC . An important role of the donor/
acceptor LUMO offset tuning approach in organic
photovoltaic devices based on metallofullerenes and
narrow-band-gap donor polymers was demonstrated.
The PCE and VOC values for the 1-[3-(hexyloxy-
carbonyl)propyl]-1-phenyl-[6,6]-Lu3N@C81 system
(Lu3N@PC80BH) reached up to 4.2% and 890 mV,
respectively. Remarkably, due to the increased size of
this EMF, the optimum blend ratio of P3HT and
Lu3N@PC80BH was 50 mass% of fullerene loading,
which is not the same for the C60-based analogue.132
Later, an organic solar cell based on Lu3N@C80 was
investigated in terms of the influence of the metalloful-
lerene on the simultaneous reduction of photocurrent
JSC .141 The reasons responsible for the decrease in JSC
were analyzed using photoluminescence and photoin-
duced absorption techniques and it was found that the
formation of triplet molecular excitons and correspond-
ing intramolecular electron transfer may decrease the
efficiency of the solar cells. The existence of triplet
excitons was also proved using photoluminescence-
detected magnetic resonance where the triplet in the
resonance spectra quenched by charge transfer in the
blends with PCBM appears in the case of a blend based
on Lu3N@C80 .
The dual role of EMFs in bulk heterojunctions was
shown by Feng et al.142 in a study on fullerene bonding
to electron acceptors in solar cells taking a conjugate of
a [6,6]-phenyl-C81-butyric acid derivative
Lu3N@PC80BM (electron donor) with 1,6,7,12-tetra-
chloro-3,4,9,10-perylenediimide (PDI) as an example.
PDI is known for its light-harvesting electron-accepting
properties. Using femtosecond transient absorption
spectroscopy, photoinduced electron transfer from the
ground state of Lu3N@C80 to the excited state of PDI
was observed, which is opposite to what occurs when
C607PDI is used. This example demonstrates that there
are many new interesting aspects in the application of
metallofullerenes in organic photovoltaics to be
explored.
Metallofullerenes of the general formula Me@C2n.
The interest in metallofullerenes in organic photovol-
taics is not limited to TNT-EMFs. Fujii et al.143 studied
the optical and photovoltaic properties of La@C82 and
reported about photoinduced charge transfer in
P3HT7La@C82 composite films. They demonstrated
the enhancement of photocurrent upon introducing a
small amount of La@C82 into the polymer, which points
to a significant role of metallofullerenes in highly
efficient photoinduced charge separation. A positive
effect of doping with Dy@C82 on the photocurrent in
a photovoltaic solar cell based on P3HT caused by
photoinduced electron transfer between donor and
acceptor was reported by Yang et al.144, 145 Using
atomic force microscopy (AFM) and absorption meas-
urements, they investigated the optimal composition of
the polymer : Dy@C82 film and revealed the formation
of a Dy@C82 segregated phase in the case of metal-
lofullerene excess in the film. More recently, successful
incorporation of Dy@C82 into polythiophene (PT) was
demonstrated.146
Stable conjugates based on La2@Ih-C80 and exTTF
were reported by Takano et al.147 The electronic inter-
action between the polymer and fullerene molecules in
the ground state was found to be relatively weak.
However, rapid formation of a radical ion pair state of
La2@C807
.
-exTTF+
.
with a lifetime of 3260 ps was
observed using transient absorption spectroscopy in the
visible and near-IR regions.
An interesting case of charge transfer in a donor-
acceptor conjugate Ce2@Ih-C80-ZnP (ZnP is zinc tetra-
phenylporphyrin) was studied by Guldi et al.148 They
revealed different strength of electronic coupling affect-
ing the charge transfer kinetics of radical ion pairs in
the conjugates. Reductive charge transfer [formation of
(Ce2@Ih-C80)7
.
-(ZnP)+
.
] was found to dominate in
nonpolar media (toluene, THF), whereas oxidative
charge transfer [formation of (Ce2@Ih-C80)+
.
-(ZnP)7
.
]
dominated in polar media (benzonitrile, DMF). This
work demonstrated the possibility to use EMFs as
electron donors and opened a new and intriguing direc-
tion of employing fullerene derivatives in photovoltaics.
Currently, the application of metallofullerenes in
photovoltaics is not yet clear. However, numerous
reports have already demonstrated that these fullerene
derivatives seem to be more promising than conven-
tional fullerenes commonly used in organic solar cells.
One of the stumbling blocks towards applying these
unique materials in photovoltaics and realization of
operating devices are the difficulties associated with
their synthesis.
Novel strategies for the chemical synthesis of metal-
lofullerenes are an important area of research. A
recently proposed methodology is the bottom-up forma-
tion of the M@C2n (M is metal; 2n=44, 50, 60, 70, 80,
90) EMFs from metal-doped graphite.149 Metallofuler-
enes were produced from graphite7metal oxide mix-
tures containing up to 2% of incorporated metal by
pulsed evaporation using a Nd:YAG laser.
III.1.c. Photocatalysis
Fullerene derivatives are being actively investigated in
the context of photocatalytic applications. The oxides
TiO2 and ZnO commonly used in photocatalysis are
inefficient in the visible region due to their wide band
gaps. Sensitization by visible light absorbing fullerene
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derivatives through the charge transfer mechanism150 is
a way to solve the problem.151 – 153
Photocatalytic activity of PCBM-modified TiO2 was
studied by Liu et al.,154 who showed that photodegra-
dation of dyes under visible light irradiation signifi-
cantly enhanced upon adsorption of PCBM on the
surface of TiO2 photocatalyst. A TiO2 powder was
mixed with PCBM sonicated in toluene and stirred.
Then, the solvent was evaporated. The fullerene deriva-
tive acted as a shuttle transferring photoexcited elec-
trons from the conduction band of TiO2 to the surface
to take part in the surface reactions. Consequently,
efficient separation of electron – hole pairs was achieved.
Oh et al.155 reported two composite photocatalysts,
C60/TiO2 and V7C60/TiO2, with enhanced photogener-
ated electron transfer. The photocatalytic efficiency of
the composites was evaluated taking degradation of
methylene blue in water under UV irradiation as an
example. Homogeneous aggregation of fullerene in TiO2
aggregates was confirmed by scanning electron micro-
scopy. Such homogeneity was supposed to lead to the
positive combination effect with increasing degradation
rate. Fullerene C60-modified TiO2 was tested as photo-
catalyst taking the degradation of salicylic acid in
aqueous solution and gaseous formaldehyde under UV
light as examples.156 The efficiency of electron – hole
pair separation and consequently the photocatalytic
activity was enhanced due to a decrease in the charge
recombination rate in the presence of C60.
Polyhydroxyfullerene (fullerenol) C60(OH)x is attrac-
tive for photocatalytic applications since this fullerene
derivative is water soluble, biocompatible, biodegrad-
able and spontaneously forms nanocomposites with
TiO2 without the requirement of expensive technological
treatment (e.g., sol – gel process). In particular, fuller-
enol C60(OH)x was used to activate TiO2 in the visible
region through the surface7charge-transfer complex
mechanism, where the electrons are photoexcited from
the adsorbate ground state (HOMO) to the semiconduc-
tor conduction band.151
A model for the formation of surface complexes and
charge transfer proposed by Park et al.151 assumes that
absorption of visible light is mediated by the formation
of covalent bonds between the titanol group :Ti7OH
and fullerenol similarly to the case of phenolic com-
pounds OH7C6H4X:
:Ti7OH+HO7C60(OH)x71
:Ti7O7C60(OH)x71+H2O
Importantly, fullerenol molecules bearing multiple
hydroxyl groups can be gripped to the titania surface
through oxygen linkages. Absorption of visible light
leads to direct excitation of electrons from the fullerenol
HOMO to the oxide conduction band without involving
the excited state of fullerenol. The resulting radical
cation undergoes recombination, thus causing one of
the limitations on the efficiency of the photocatalytic
process. The application of fullerenol to photocatalysis
in the visible region for the reduction of CrVI, degrada-
tion of 4-chlorophenol (4-CP) and H2 generation was
successfully proved in another study.151
An interesting example of combined bulk and surface
modification of TiO2 with fullerenol was reported.157
The surface adsorption of C60(OH)x was used for photo-
sensitization of titania. Also, the ‘bulk’ Nb-doping was
initially applied to increase the electron concentration
and transport efficiency due to the charge compensation
as a result of Nb-substitution of Ti ions.158 The photo-
catalytic properties were tested using the photoinduced
oxidation of 4-CP and iodide to triiodide as well as
photoreduction of CrVI. The visible light photocatalytic
performance of fullerenol/Nb-TiO2 nanoparticles was
found to be higher than in the case of non- or single-
modified (through either Nb-doping or fullerenol sensi-
tization) samples. The improvement of efficiency was
described as being due to the synergistic effect of the
modification with fullerenol and Nb-doping causing the
formation of defects. The latter reduced the electron
transfer from fullerenol and charge recombination.
Fullerenes and their derivatives can be used for
application in oxidative damage in biological objects
and cellular systems as ROS through photosensitization
involving UV or visible light.159, 160 Fullerene C60 and
C60(OH)18 have the potential to damage biological
membranes in both hepatic and tumour microsomes via
the action of 1O2 and other radical species, respec-
tively.161
Enhancement of UVA-photocatalytic performance of
a fullerenol/TiO2 nanocomposite in transparent antimi-
crobial coatings was demonstrated.162 A comparison of
the organic dye degradation and fungal spore inactiva-
tion kinetics on the photocatalytic and non-photocata-
lytic surfaces revealed a significant increase in the rate
of both processes. Optimization tests made it possible to
determine the most efficient fullerenol/TiO2 ratio in the
nanocomposites studied when the titania surface
becomes saturated with the functionalized fullerene.
The enhanced photocatalytic activity of titanium
dioxide modified with fullerenol was studied by Krishna
et al.163, 164 It was shown that the fullerenol additives
enhance the hydroxyl radical generation and degrada-
tion of Procion red dye which is accelerated by a factor
of up to 2.6. The rate of inactivation of Escherichia coli
was found to be almost two times higher for the
modified TiO2. The authors also discussed the potential
of fullerenol as a scavenger of hydroxyl radicals, which
were expected to decrease the efficiency of photocatal-
ysis, and concluded there would be a limited role of C60
(OH)x as a scavenger due to the short lifetime of the
hydroxyl radical. However, fullerenol can successfully
scavenge the photogenerated electrons from titanium
dioxide, which leads to faster generation of the
.
OH
radicals.
It was proposed to use fullerene derivatives for
photosensitive ROS generation and subsequent inactiva-
tion of MS2 bacteriophage under UV irradiation.165 The
production of singlet oxygen 1O2 and superoxide radical
anion Oÿ2
.
(key factors of MS2 inactivation) by full-
erenol in these conditions was confirmed by EPR and
reduction of nitrotetrazolium blue.
Brunet et al.166 tested the ROS production in aque-
ous suspensions of fullerenol and a complex of PVP
with fullerene C60 and compared it with nano-TiO2.
They found more efficient 1O2 generation by the
hydroxylated and polymer-coated fullerenes. However,
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no hydroxyl radical production was detected in both
cases.
The efficiency of novel fullerene C60 derivatives for
photocatalytic applications including antimicrobial was
shown to be higher than that of fullerenol.167 Four
NH3 -, CO2H- and OH-terminated multi-functionalized
fullerene C60 derivatives were synthesized using high-
purity C60 and malonate analogues. These materials
exhibit unique photochemical properties, especially in
photoinduced bacterial and virus inactivation. These
agents had a much higher efficiency as compared with
fullerenol and TiO2 . Interestingly, the lifetime of the
triplet states of the functionalized C60 derivatives was
comparable with that of pristine C60 samples and much
longer than that of fullerenol. Such intrinsic energy
transfer is responsible for efficient 1O2 production by
these derivatives in water despite the formation of large
particles due to aggregation.
The photocatalytic properties of fullerenes are of
interest for hydrogen energetics. The photoelectrochem-
ical activity of n-type organic semiconductors based on
PCBM and 3,4,9,10-perylenetetracarboxylic dianhydride
(PTCDA) was studied.168 Three-layer PTCDA/
PTCDA:PCBM/PCBM photoactive anodes of water
splitting cells for H2 generation have been constructed
and tested for stability. The efficiency of this structure
was shown to be higher than that of the one- or two-
layered anode structures. The possibility of generating
hydrogen and oxygen in almost a stoichiometric ratio
(2 : 1) was demonstrated in a three-electrode cell with the
mixed layer. This result can be associated with two
possible paths of charge separation under illumination
with visible light depending on what component (PCBM
or PTCDA ) is first excited.
III.2. Membrane technology
Membrane processes are widely used for purification of
natural water and wastewater and for concentration and
fractionation of industrial liquid and gas mixtures.
Owing to environmental and material advantages, mem-
brane methods have been extensively developed and
applied in various fields.169 – 171 Rapid progress of mem-
brane techniques requires the design of new membrane
materials with improved transport and physicochemical
properties. In this connection, modification of well-
known polymer materials with fullerene and fullerene
derivatives seems to be promising. This approach and
the applications of the thus-modified materials in dif-
fusive processes,4, 5 pressure-driven processes 6 – 11 and
fuel cells 3 have been documented.
III.2.a. Diffusive membrane processes
Mixed-matrix membranes are most widely used in dif-
fusive membrane processes, viz., pervaporation and gas
separation, since carbon nanomodifiers change the crys-
tallinity of polymer matrices, the mechanical properties
and the free volume of polymer membranes. Studies on
the properties of hybrid membranes in diffusive mem-
brane processes allow one to evaluate the contribution
of modification to the transport properties of polymeric
membranes.
In pervaporation, separation of low-molecular-mass
liquids occurs due to diffusion through a membrane.172
This method is used for the separation of azeotropic
mixtures, mixtures of isomers and thermally unstable
substances. Since pervaporation is a low-power and eco-
friendly technology, it is used in various fields, espe-
cially in chemical 173 and petrochemical 173, 174 industries
and in biochemistry.175 The main characteristics influ-
encing the selectivity of the pervaporation process
include the structure and chemical nature of the mem-
brane.
Membranes based on the PVA – fullerenol C60(OH)n
composites (n=12, 22 – 24) were prepared.13, 176, 177 It
was shown that PVA forms hydrogen or covalent bonds
with fullerenol depending on the cross-linking method.
The structure of the PVA – fullerenol membranes with
hydrogen bonds is shown in Fig. 10.
The transport properties of membranes in the dehy-
dration of different types of binary and multicomponent
systems were studied by pervaporation. It was shown
that the fullerenol-modified PVA membranes had differ-
ent transport properties depending on the cross-linking
procedure,176 namely, heat-treated membranes had high
selectivity but low permeability, while the membranes
chemically treated by maleic acid had high selectivity
and permeability. During the separation of water – alco-
hol mixtures 176 using chemically cross-linked PVA-full-
erenol membranes the flux increased by 260%. The same
result was obtained in the study of the synthesis of n-
propyl acetate using a hybrid process ‘esterification with
pervaporation’.177 During the separation of the n-prop-
anol – n-propyl acetate – water ternary azeotropic mix-
ture the flux increased by 170% compared to the
unmodified PVA membrane.177 All membranes were
highly selective to water. These results show a promise
in the application of these chemically cross-linked mem-
branes in the separation of water-containing mixtures.
The mechanism of the gas separation process is
similar to that of pervaporation. Like in pervaporation,
the separation of gaseous mixtures proceeds by the
‘solution7diffusion’ mechanism by diffusion of gas
molecules through a nonporous membrane.
To improve the gas barrier properties of thermo-
plastic polyurethane elastomers (PUE), fullerenol
C60(OH)6712 and a polyurethane fullerene derivative
PVA
Fullerenol
Figure 10. The structure of non-heat-treated PVA7C60(OH)22724
membranes.176
Dashed lines denote hydrogen bonds.
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prepared by the chemical modification of fullerenol were
added as fillers.178 To study the transport properties,
the O2 and CO2 permeabilities were investigated. It was
shown that the decrease in the gas permeability of the
modified membranes is due to inhibited diffusion of gas
molecules by fullerene particles (this fact was confirmed
by changes in the diffusion coefficient with temperature)
rather than changes in the hole volume which varied
only slightly for the neat and modified membranes. It
was found that the gas barrier properties of the polyur-
ethane fullerene derivative improved almost fourfold for
O2 and fivefold for CO2 as compared to fullerenol. The
addition of fullerenol (5 mass%) reduced the gas per-
meability by about 10% – 20%, which was explained by
higher dispersibility of the polyurethane fullerene deriv-
ative in thermoplastic PUE compared to that of full-
erenol.
III.2.b. Fuel cells
A fuel cell converts the chemical energy of fuel and an
oxidant into electricity. Fuel cells consist of an anode, a
cathode and an electrolyte. The anode and cathode
contain catalysts that cause the fuel to undergo oxida-
tion reactions that generate positively charged hydrogen
ions and electrons.
The main challenges affecting the commercialization
potential of fuel cells are their performance, reliability,
durability, and cost. Polymer electrolyte membrane
(PEM) fuel cells or proton-exchange membrane fuel
cells consist of a polymer electrolyte sandwiched
between two electrodes to form a membrane-electrode
assembly.
PEM fuel cells have been considered as candidates
for use in different fields since they can vary their
output quickly to meet shifts in power demand and
thus are suited for applications requiring quick
startup.179 Water management is one of the most diffi-
cult issues in operating polymer electrolyte fuel cells. A
breakdown in water balance at the cathode side often
results in water flood, while the anode interface with the
membrane may suffer from water depletion due to water
transportation by electro-osmotic drag.
Tasaki et al.180 modified the Nafion1 117 mem-
branes with fullerene C60 and fullerenol C60(OH)12 .
The modified membranes had higher proton conductiv-
ities and held more water than the parent Nafion
membranes, especially at low RH<50%. The compo-
site Nafion7C60 (1 mass%) was characterized by
increased dry water uptake and a higher conductivity
compared to the Nafion7fullerenol composite despite
its hydrophilicity. The results obtained were explained
by the presence of interfacial water (extra water)
between the C60 particles and the Nafion domain and a
likely morphological change in the Nafion membranes.
Postnov et al. 181 prepared Nafion – fullerenol
(C60(OH)n (n=22 – 24), C70(OH)12) and Nafion – tris-
malonate C60[C(COOH2)3] composite films and studied
their proton conductivity at different RH levels. The
composite containing 1.7 mass% of tris-malonate dem-
onstrated the maximum proton conductivity at low RH,
viz., nearly 6.361075 S cm71 at RH= 32%, which was
about 30 times higher than that of pure Nafion. The
Nafion – fullerenol composite films containing from
1 mass% to 6 mass% of dopant showed no significant
dependence of conductivity on the concentration and
type of dopant.
PEM fuel cells transform hydrogen and oxygen gases
into water and electricity. However, the complicated
reaction pathway to do this transformation needs a
catalyst to be efficient. Platinum is an effective catalyst
for the hydrogen oxidation reaction and the oxygen
reduction reaction in PEM fuel cells, but it is also an
expensive one. The expense and the stability problems
for platinum/carbon black catalysts have led scientists
to search for alternative catalyst materials. Metalloful-
lerenes have also been suggested as alternative catalysts
with ultralow Pt loading. Since fullerene C60 is rather
stable, a metallofullerene also may appear to be stable
enough to decrease carbon corrosion and at the same
time to maintain the catalytic activity on the metal
atom(s).{
III.3. Biomedical applications
The study of the biological properties of fullerenes is
important from both theoretical and practical perspec-
tive because it is important to identify and assess the
potential of these fundamentally new structures.
Studies on the possibility of using fullerenes in drug
design started fairly quickly after their discovery.182, 183
This was 4,40-bis{[2-(2-carboxyethyl)carbonylamino-
ethyl]phenyl}-(30H-cyclopropa[1,9](Ih-C60)[5,6]fullerene,
which can block the hydrophobic cavity of HIV pro-
tease.
Since then the number of studies on the biological
activity of fullerene has increased and currently reaches
thousands of articles annually. In this review only some
of the recent publications on the general problem and
some unusual aspects 184 – 190 will be mentioned. This
Section focuses mainly on those examples of the appli-
cation of fullerenes and their derivatives where the role
and use of polymers are significant.
The biological activity of fullerenes, as any other
class of compounds, is determined by the physical,
chemical and topological properties of their molecules.
The most important physical property of fullerene mol-
ecules is their ability to convert triplet oxygen into a
variety of ROS. The most important chemical property
is the unsaturated nature of the molecules, which makes
them active radical scavengers.
Furthermore, fullerene molecules can form covalent
bonds and supramolecular conjugates with various types
of molecules including macromolecules. Another crucial
feature of the fullerene molecules, distinguishing them
from the majority of other organic compounds, is the
presence of an internal cavity, which can include a
variety of atoms or groups of atoms. Endohedral full-
erenes can be very useful in the development of contrast
agents for different types of tomography (see below).
Using EMFs, it is also possible to engineer thera-
nostic agents, i.e., single agents that are both therapeu-
tic and diagnostic by design.191, 192 The rigid shape
(sphere for C60) allows them to react with various
{ See M A Gabriel, T Deutsch, A A Franco ECS Trans. 25 (22) 1 (2010);
M A Gabriel, L Genovese, G Kronsicki, O Lemaire, T Deutsch,
A A Franco Phys. Chem. Chem. Phys. 12 9406 (2010).
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biological molecules and structures. The driving force of
this interaction is lipophilicity.
Therefore, fullerenes C60 , C70 and higher analogues,
as well as their derivatives can be used in medicinal
chemistry as:
— photosensitizers for photodynamic therapy
(PDT);
— antioxidants; and
— membranotropic compounds.
On the basis of fullerenes and their derivatives it is
possible to design:
— antitumour and antiviral chemotherapeutic
agents;
— contrast agents;
— vehicles for drug or gene delivery systems; and
— diagnostic and theranostic agents.
However, there are two challenges that complicate
the study of the biological activity of fullerenes. At first,
fullerenes are almost entirely insoluble in water, which
reduces the availability of biologically active mole-
cules.193 Secondly, hydrophobic fullerene molecules
tend to form aggregates. At the same time, it is well
known that the physicochemical and biological proper-
ties of fullerenes can significantly influence the develop-
ment and degree of biological response.194
Aggregation leads to fundamental differences in the
interaction of single fullerene molecules and fullerene
nanoparticles with biological structures due to not only
different properties, but also different size. The size of
fullerene molecules is quite biological. For instance, the
C60 molecule is *1 nm in size, which is biologically
attractive. But this is valid only for isolated molecules,
because aggregate forms of C60 represent nanoparticles.
For example, a small C60 fullerene molecule can embed
into a human serum albumin (HSA) molecule having a
size of 8.063.8 nm.195, 196 However, nanoparticles
behave in a completely different manner, namely, HSA
molecules adsorb onto the surface of C60 nanoparticles
in an aqueous dispersion, the process being accompa-
nied by changes in the conformation of the protein
molecules.197
As a result, depending on the degree of aggregation,
we deal with a fullerene molecule on (or within) a
biological molecule. Yet another consequence of aggre-
gation is the weakening of the photosensitizing ability of
crystalline C60 (fullerite) compared to that of C60 in
solution because the triplet state of fullerite undergoes
rapid self-quenching.198
In some cases, the difference is more dramatic. For
example, no ROS production from nano-C60 cluster
prepared by prolonged sonication of a mixture of full-
erene C60 with water was detected.199 Therefore, it is
obvious that the chemical nature of fullerene impacts its
physical behaviour by bestowing unique optical and
electronic properties, solubility, particle size and disper-
sion behaviour, which in turn dictate its interactions
with biological entities.
Fullerenes in biological systems. There are several
possible ways to introduce fullerenes into biological
systems. One can use fullerite suspensions or aqueous
colloidal dispersions (nano-C60).200, 201
In the fullerite and nano-C60 particles the active
entity is always the same, namely, pristine C60 as nano-
particles or some other forms. However, the sizes of
these particles vary over a wide range, e.g., from 200 to
1000 nm or more for suspensions 202 and from 50 to
600 nm for colloidal dispersions.203 In the latter case,
the particle size depends on the method of preparation.
The other way is to prepare water-soluble composi-
tions, viz., covalent derivatives containing polar groups
or supramolecular complexes with polymers.
Polyhydroxylated fullerenes, or fullerenols, are very
often used. The formula C60(OH)n corresponds to the
structure averaged over a mixture of fullerenols bearing
different number of hydroxyl groups, each with its own
stereoisomers. The solubility of fullerenols depends on
the number of hydroxyl groups. Water-soluble fullere-
nols contain 20 or more OH groups. However, full-
erenols have a significant disadvantage: in one of the
first studies the authors pointed out that samples pre-
pared in the same way nevertheless show a variability of
both water solubility and biological effects, presumably
reflecting uncontrolled differences in the number and
location of oxygen-containing addends in the fullerene
core.204 The structures of some other fullerene deriva-
tives (e.g., some amino acid derivatives 205) are also not
always determined accurately. Nevertheless, for some
compounds, the structures were defined accurately.206
As mentioned above, there is a problem of aggrega-
tion originating from the hydrophobic nature of the
fullerene core. The fullerene core strive to aggregation
is so strong that often the attachment of only one
substituent to the core is not enough to prevent it.
Fullerene derivatives can form morphologically different
nanoscale structures (spheres, nanorods and nanotu-
bules) in water depending on the nature of the side
chain attached to the fullerene core.207, 208
Therefore, fullerene molecules in biological systems
simultaneously behave as molecules and nanoparticles.
For example, they form aggregates in a solution but
decompose into individual molecules and small aggre-
gates (dimers, trimers) inside the membrane.209 Even for
nano-C60, the cluster size depends on the method of
preparation.210
Aggregation also leads to differences in the interac-
tion with biological molecules. In particular, nano-C60
clusters with a particle size of more than 50 nm cannot
enter into cell membranes whose thickness is merely 5 – 7
nm. Differences in the interaction of fullerene molecules
and nanoparticles with proteins were discussed
above.195, 197, 211
The same thing happens to fullerenes interacting
with nucleic acids. In particular, only aminofullerenes
can bind nucleic acids (these ionic complexes are used
for gene delivery, see below).212 – 214 However, fullerene
aggregates (nano-C60) can adsorb onto the surface of
single-stranded DNA (ssDNA). Although the nano-C60
particles are negatively charged, ssDNA binds them due
to strong p7p stacking interactions between DNA bases
and nano-C60 .215
A detailed analysis of the impact of the number and
type of substituents on the solubility of fullerene deriv-
atives in water and on their ability to aggregate shows
that at least three ionic groups attached to the fullerene
core are required to obtain a water-soluble form.206
However, a drawback of multiple exo-functionalization
is stronger disruption of the fullerene p-system with
increasing number of addends. As a direct consequence,
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the antioxidant or neuroprotective activities should
decrease due to a lower electron or radical affinity.216
Therefore, one of the most convenient ways is to
synthesize dendrimer-type adducts since in this case it
is possible to attach several polar groups and each
addend does not strongly shield the fullerene core. For
instance, the solubility of monoadduct I (second-gener-
ation dendrofullerene, Fig. 11) in water is 1.261072
mol litre71, which is one of the highest values for
fullerene derivatives.218
This substitution pattern also leads to another result,
namely, due to the very effective shielding of the full-
erene surface by the bulky dendritic branches, this
compound is dispersed in monomeric form at a neutral
pH.219 Nevertheless, replacement of only one dendritic
ligand by lipophilic octadecyl moiety results in a highly
amphiphilic compound which aggregates into large clus-
ters. The positively charged monoadduct II (Fig. 12) {
with three ethylene glycol chains is water soluble at
concentrations around 1075 mol litre71, but the addend
does not shield the fullerene core, and therefore II
shows a pronounced tendency to form aggregates.219
However, the result is not good if both polymeric
addends contain no charged groups. The nonionic but
polar analogue of I (see Fig. 11) with two PEG chains is
almost insoluble in water.
Nevertheless, obtaining a water-soluble fullerene
derivative without charged ionic groups is possible. A
derivative of 1,9-dihydro-1a-aza-1(2)a-homo(Ih-C60)[5,6]-
fullerene III (‘sugar ball’, see Fig. 12) containing six
a-D-mannose units is a good example. This compound
is water soluble and forms only small micelles.220
Thus, using various polymers and fullerene deriva-
tives, complexes with different solubility and aggrega-
tion ability can be obtained. In almost all cases, the
most suitable compound for a given biological target
can be synthesized.
One more widely used approach is the preparation of
water-soluble compositions by forming supramolecular
complexes with hydrophilic polymers. These can be
noncovalent water-soluble inclusion complexes with var-
ious biocompatible polymers, viz., PVP (C60/PVP com-
plex),221 poly(2-ethyl-2-oxazoline) homopolymer (C60R/
PEtOx complex) 222 and a water-soluble diblock copoly-
mer, poly(N-isopropylacrylamide)-b-poly(N-vinyl-2-pyr-
roridone).223 Fullerenes can be included in
liposomes,224, 225 encapsulated in Triton X-100
micelles,226 dissolved in PEG 227, 228 and solubilized
through complexation with disaccharides.229 To form
supramolecular complexes with cyclodextrin-like struc-
tures and liposomal forms, surfactants can be used.
Fullerene C60 can also form water soluble supra-
molecular complexes with substituted cyclotriveratry-
lene.230 All these forms differ in the fullerene
concentration and in the degree of fullerene aggregation
(e.g., the degree of aggregation in the C60/PVP complex
depends on the molecular mass of PVP and fullerene
concentration 231).
In some cases, such as compositions for topical
cutaneous application, solutions of fullerene C60 in
squalane and squalene can be used.232, 233 A solution in
a lipophilic solvent (olive oil) can also be used for oral
administration of fullerene C60.2 It should be noted that
aggregation of fullerene molecules in an inclusion com-
plex of fullerene with g-cyclodextrin C60/2g-CD is
impossible.234, 235
Fullerenes in membranes. To predict or at least
understand the biological properties of fullerenes and
their behaviour in the body, one should know how they
interact with lipid membranes. At low concentrations,
fullerenes are present in the phospholipid membrane as
single molecules. Their preferred location in the mem-
brane is only slightly influenced by the derivatization
because of the key role played by dispersion interactions
between the highly polarizable fullerene cage and the
tight hydrocarbon chains.236
Particular attention should be paid to two fullerene
derivatives, viz., trisadducts e,e,e-C63(COOH)6) (C3) and
trans-3,trans-3,trans-3-C63(COOH)6) (D3). They can be
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Figure 11. Dendritic water-soluble fullerene mono-adduct of fullerene C60 I.217
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Agents Chemother. 40 2262 (1996).
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synthesized with ease by the Bingel reaction and are well
soluble even in neutral water. That is probably why they
are the most frequently studied fullerene derivatives
with respect to the antioxidant and neuroprotective
activity in vitro and in vivo.206
It is these carboxyfullerens that provide one of the
most striking examples of the contribution of membra-
notropic properties to the biological activity. Both
compounds are powerful scavengers of hydroxyl radicals
and superoxide radical anions.204 However, they differ
markedly in neuroprotective action and in effects on
tissue cultures. According to EPR data, this is due to
the difference in the interaction with membranes.204
The influence of membranotropic properties of these
compounds is clearly seen when comparing their anti-
viral action. Namely, carboxyfullerene C3 (10 mmol
litre71) inactivated the Dengue-2 virus under illumina-
tion (i.e., by the photochemical mechanism involving
production of singlet oxygen or other ROS). This com-
pound also could inactivate the Dengue-2 virus without
light when its concentration was increased to 40 mmol
litre71.237 A study of the effect of C3 on the Japanese
encephalitis virus (JEV) and two nonenveloped viruses
[viz., Enterovirus 71 (EV71) and Coxsackie virus B3]
revealed that this fullerene derivative selectively inacti-
vated enveloped viruses (Dengue-2 virus and JEV), but
was inactive against nonenveloped types,237 which indi-
cates possible involvement of a light-independent mech-
anism in the blockade of viral replication in the
attachment and penetration stages.237 Antimicrobial
and bactericidal properties of fullerene derivatives are
also associated with their membranotropic proper-
ties.200, 238
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Antiviral effect of fullerene C60 in a complex with
PVP is based on the interaction with membranes. This
complex inhibits reproduction of influenza virus and can
inhibit reproduction of DNA-containing viruses, in
particular, herpes simplex virus.239 An electron micro-
scopy study of the intact influenza type A virions and
the virions treated with the C60/PVP complex showed a
change in their morphology, namely, there were many
defect virions and virions with damaged ‘brush’ and
disturbances of lipid envelopes.240
The envelopes of viruses and bacteria are composed
of not only lipids, but also proteins. Consequently, the
aforementioned ‘dark’ antiviral effect of C3 and viruci-
dal action of C60 are most likely based on membrane
destruction due to the interaction of fullerene molecules
with proteins.
All the above data clearly demonstrate that the
properties of the fullerene core (e.g., lipophilicity) can
play a crucial role in the interaction of fullerene and
fullerene derivatives with biological objects in vitro and
in vivo. However, it should be emphasized that fullerene
molecules exhibit their membranotropic properties at
low degree of aggregation only.
Fullerenes in photodynamic therapy. One of the fields
where fullerenes may have a medical application is the
light-based therapy called photodynamic therapy (PDT),
which is a nonsurgical, minimally invasive approach
that has been used in the treatment of solid tumours
and many nonmalignant diseases.241 Both pristine full-
erenes C60 and C70, as well as their derivatives, increase
the intracellular ROS level, and so in biological systems,
they are oxidants 242 and induce apoptosis.243 They can
therefore be lead compounds for antiviral and anti-
cancer drug design.244 – 246 Some relevant examples
were given above (see also Refs 159 – 162).
The advantages of fullerenes over the traditional
photosensitizers used for PDT are as follows:
— fullerenes are more photostable and undergo less
photobleaching than many other photosensitizers;
— fullerenes show both kinds of photochemistry
comprising type I (free radicals) and type II (singlet
oxygen);
— fullerenes can be chemically modified for tuning
their structures for the given activity in the given
system;
— a light-harvesting antenna can be attached to the
fullerene core in order to enhance the overall quantum
yield and the ROS production and to extend the
absorption spectrum of the photosensitizer in the long-
wavelength region; and
— molecular self-assembly of fullerenes into vesicles
allows improved drug delivery and can produce self-
assembled nanoparticles with tropism to different tis-
sues.184, 247
The first demonstration of the photodynamic action
of fullerene was the inactivation of enveloped viruses by
fullerite suspensions.248 Incorporation of fullerenes into
polymeric environment usually does not deprive their
photosensitizing properties, viz., pristine C60 exhibits
pronounced cytotoxicity under illumination with visible
light in lipid membranes with a cationic surface 249 and
in PEG-based block copolymer micelles.250 Fullerene
C60 in a complex with PEG demonstrates anticancer
activity against fibrosarcoma cells, the effect being
dependent on the concentration of the PEG – fullerene
C60 complex and irradiation doses.227, 228
The photodynamic properties of fullerene C70 have
also been widely studied. A comparison of the photo-
dynamic activity of fullerenes C60 and C70 encapsulated
in dimyristoylphosphatidylcholine liposomes against
HeLa cells showed that C70 was five times more active
than C60 . The difference has been attributed to an
improved absorption spectrum of fullerene C70 .251 The
photodynamic activity of C70 and C84O2 fullerene deriv-
atives functionalized with decacationic ethyleneamine
chain was also described.252
It is known that aggregation weakens the photo-
sensitizing properties. However, only aggregation lead-
ing to strong shielding of the fullerene core is
undesirable. Aggregation of the entire polymer subunit
may not influence the photosensitizing ability of a given
compound provided that there is an oxygen generator
near the fullerene core and the core is accessible to
illumination.
For example, a fullerene-acrylamide copolymer IV
can form particles with an average diameter of about
46 nm. The formation of ‘nanoballs’ does not affect the
photodynamic activity of fullerene, thus indicating that
aggregation does not lead to shielding of the fullerene
core and is associated with the polymer system
(Fig. 13).253
Yet another advantage of the use of polymers in the
design of systems for photodynamic therapy is that the
conjugate of fullerene C60 with PEG is accumulated
predominantly in tumour tissue and can therefore be
used for selective photodynamic action on the
tumour.254
Modification of fullerene C60 with polysaccharide
pullulan results leads to an effective photodynamic
antitumour agent.255, 256
Mono- and polycationic fulleropyrrolidines can also
be used as photosensitizers.257, 258 These functionalized
C60 fullerene derivatives are efficient broad-spectrum
antimicrobial photosensitizers.259, 260 Structure – activity
studiess 258 showed that the most efficient antimicrobial
photosensitizers are the quaternary C60 fullerene deriv-
atives. It was assumed that they may be useful for the
treatment of superficial infections, where light penetra-
tion into tissue is not problematic, e.g., in wounds and
burns.
A major challenge in PDT is the limited tissue
penetration due to light absorption and scattering by
biological tissues. Photosensitizing molecules which can
only be excited by short-wavelength light (UV and blue
light) are usually unfavorable in cancer therapy, espe-
IV
NH2
O
n
Figure 13. Fullerene-acrylamide copolymer IV.
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cially for solid tumour treatment, due to their extremely
small tissue penetration depth.
The challenge can be overcome by inducing a red
shift in the absorption spectrum through attachment of
an electron-donating antenna to the fullerene core.
To this end, two compounds, namely, decacationic
C60 fullerene derivative V and a conjugated monoadduct
VI with a red light-harvesting antenna (Fig. 14) were
synthesized. A study 261 on the possibility of using these
compounds for cancer treatment on a HeLa cell model
showed that attachment of the antenna VI enhances the
photodynamic activity upon excitation by longer-wave-
length light.
It is not necessary for a light-harvesting antenna
moiety to be a fullerene addend. The antenna molecule
can be included into lipid membrane bilayers together
with fullerene C60 molecules.262 For additional informa-
tion on the light-harvesting antenna systems, see
Ref. 47.
Polymers can ‘help’ fullerenes in the manifestation of
biological activity, and fullerenes can enhance the bio-
logical effects of some oligomers. For example, squa-
lene, (6E,10E,14E,18E )-2,6,10,15,19,23-hexamethyltet-
racosa-2,6,10,14,18,22-hexaene, an isoprenoid com-
pound structurally similar to beta-carotene, can be
used as an anticancer substance, antioxidant, drug
carrier, detoxifier, skin hydrator and emollient both
in vivo and in vitro.263
At the same time, a solution of fullerene C60 in
squalene (C60/Sqe) inhibited lipid peroxidation more
markedly (1.2-fold) than squalene alone.233 An assay
showed that combining C60/Sqe treatment and X-ray
irradiation caused the lipid peroxidation level as
malonic dialdehyde equivalent to increase in a manner
dependent on X-ray dose.233
Fullerenes and biological polymers. Studies on the
interactions of fullerenes and their derivatives with
proteins and nucleic acids to form hybrid functional
assemblies is a relatively new and promising research
area.
Friedman and coworkers 182, 264 were the first who
proposed the interaction of fullerenes with proteins.
They assumed that the action of fullerene as HIV
protease inhibitor is related to its ability to embed into
the cylindrical cavity of the enzyme as a result of strong
hydrophobic interaction between the C60 fullerene core
and amino acid residues in the cavity region.265
The available data on the interaction of fullerenes
with biopolymers (proteins and nucleic acids) can be
divided into two groups. One group includes the results
which imply noncovalent or covalent interaction of
fullerenes and their derivatives with polymers (indirect
data based on biological response). The other group
includes the results containing direct evidence of the
formation of covalent or supramolecular fullerene –
polymer complexes.
Studies which imply but do not directly show the
interaction of fullerene or its derivatives with proteins
first of all include the publications containing data on
the effect of fullerenes as agonists or antagonists of
receptors or enzymes, e.g., the inhibitory effect of full-
erene derivatives on glutathione reductase 266 and inac-
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tivation of neuronal nitric oxide synthase by compounds
C60C(COOR)2 [R= (CH2)3OH or (CH2)3NH

3 ] (Ref.
267) or trismalonates C60[C(COOH)2]3.268
Fullerenols C60(OH)n (n=18 – 20) were found to be
glutamate receptor antagonists that inhibit the gluta-
mate binding in dose-dependent manner.269 Cationic
bis-N,N-dimethylfulleropyrrolidinium salts are noncom-
petitive inhibitors of acetylcholinesterase.270 More such
examples can be found.
Fullerene derivatives can not only inhibit the action
of enzymes, but also increase their expression, as is the
case with the adenosine A1 and A2A receptors in SK-N-
MC cells after treatment with the tetracationic fullerene
derivative VII (Fig. 15).191, 271
One of the most striking proofs of the ability of
fullerenes to interact with proteins is the formation of
fullerene-specific antibodies obtained for the water-solu-
ble C60 and C70 fullerene derivatives.272 An X-ray study
of a Fab fragment of an antibody showed that the
fullerene-binding site contains amino acids of both
chains. The site is formed by a cluster of hydrophobic
amino acids; some of them are involved in p – p-stacking
interactions with the fullerene core. The authors believe
that the interaction proceeds by the induced fit mecha-
nism.273 The anti-fullerene C60 antibodies can also be
produced using fullerenecarboxylic acids, thyroglobulin,
BSA, etc.274
The formation of antibodies to fullerenes has a high
theoretical significance because it demonstrates almost
unlimited potential of the immune system, which can
recognize even such an unusual structure as the fullerene
molecule. There is also a practical value. Indeed, the
application of fullerenes requires the development of
relevant methods for the determination of these com-
pounds in biological tissues and fluids and the immuno-
assay belongs to the most sensitive and relatively simple
techniques. In particular, it is immunoassay that was
used to determine the distribution of carboxyfullerene
C61(COOH)2 within the cells.275
p – p-Stacking interactions can occur between the
p-system of the fullerene core and aromatic amino acid
residues.276 An example of the direct interaction is
provided by the synthesis of a ‘peptide receptor’, i.e., a
nonapeptide made up of six a-aminoisobutyric acid
residues, a Gly spacer and two L-Tyr residues in posi-
tions 2 and 8 (here, hydroxyl groups were replaced by
the ferrocenoyl moieties).277 It was shown that the
ability of this peptide to host fullerene C60 is due to
the presence of electron-rich hydrophobic cavity formed
by the ferrocenoyl residues.
Various complexes of fullerene C60 and its deriva-
tives with natural proteins are available (Table 1). They
were obtained by mixing aqueous solutions of fullerene
C60 and lysozyme 278 as well as aqueous solutions of the
trismalonate C3 and proteins.279, 280 Exchange reaction
between supramolecular complexes of fullerene C60 with
g-cyclodextrin or PVP with proteins in solutions were
used.176, 281
The ability of fullerenes to form complexes with
blood transport proteins (BSA and HSA) can be treated
as a model for the interaction between carbonaceous
nanomaterials and biomacromolecules and transport in
biological systems. The exchange reaction between the
C60/lactoglobulin complex and HSA can be regarded as
a model for carbonaceous nanomaterial delivery
through epithelial barriers to the blood transport pro-
teins.282
Experimental data and results of molecular docking
calculations suggested that an amphiphilic, negatively
charged ligand is bound to the HSA subdomain IIA
(binding site is formed by hydrophobic side chains, with
the entrance to the pocket being surrounded by pos-
itively charged amino acid residues). The binding con-
stant of the C3 isomer of trismalonic acid was found to
be comparable with the published values for other
organic molecules that strongly bind to the same HAS
site, namely, bilirubin, iodipamide and some others.284
Fullerene C60 docking sites were studied 210 for more
than 1200 proteins using the available experimental data
on protein7C60 interaction.
Fullerenol C60(OH)20 can also interact with proteins,
in particular, microtubules to give inclusion com-
plexes.285 Microtubules are the main component of the
cytoskeleton and fullerenol inhibits their polymerization
by the formation of a complex with tubulin in a molar
ratio of 9 : 1.
Fullerenes can also influence the secondary structure
of proteins. For instance, a water-soluble organo-
phosphorus derivative of fullerene,
C60Om(OH)n[C(PO3Et2)2]p (m& 8, n& 12, p& 1), forms
a complex with HSA and disturbs the protein structure,
viz., the number of a-helices and b-sheets increases while
that of b-turns decreases. As a result, the protein
becomes more compact upon association.286
Table 1. Fullerene complexes with proteins.
Fullerene derivative Protein Ref.
C60 Lysozyme 278
C60 BSA 281
C60 BSA, transthyretin 176
C3 HSA 281
C3 b-Lactoglobulin, HSA 282
C60, C3 BSA, HSA, HIV protease, 283
fullerene-specific antibody
C3 Apomyoglobin 280
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Figure 15. Tetracationic fullerene C60 derivative VII.271
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Specific interaction between fullerene and proteins at
the molecular level was mentioned above (see, e.g., Ref.
278). However, it can also occur at the nanoparticle
level. For example, nano-C60 can interact with and
modulate the function of Ca2+/calmodulin-dependent
protein kinase II (CaMKII), a multimeric intracellular
serine/threonine-specific kinase central to Ca2+ signal
transduction, by a mechanism that competes with the
well-documented interaction between the NMDA recep-
tor subunit NR2B and CaMKII.287 The example of
specific interaction between nanoparticles and cellular
signalling proteins may have significant implications for
the potential therapeutic applications of fullerene C60 .
Amyloid deposits are implicated in the pathogenesis
of many neurodegenerative diseases, e.g., Alzheimer’s
disease. A fullerene C60 derivative, 1,2-(dimethoxylme-
thano)fullerene, inhibits the early stages of aggregation
of b-amyloid peptides, the interaction being complemen-
tary. It was assumed that this compound can specifically
bind to the central hydrophobic motif KLVFF, thus
suppressing Ab-fibrillation.288
The ability of fullerene C60 derivatives to inhibit the
aggregation of amyloid peptides has repeatedly been
shown 289 – 292 (see also a review 293). It was assumed
that C60 preferentially binds to the core part of the
fibril and destabilizes the fibril structure.294 A signifi-
cant role in the inhibition of the Ab(16 – 22) fragment is
also ascribed to the fullerene six-membered rings.295
Recent developments in the hybridization of carbon
nanomaterials and amyloid fibrils, as well as the state
of the art in the application of carbon nanomaterial –
amyloid fibrils hybrids in bionanotechnology have been
documented.296, 297
Inhibition of b-sheet formation has been considered
as the primary therapeutic strategy for Alzheimer’s
disease. Therefore, the results obtained in vitro and in
vivo provide hope that further work will give some
possibilities for preventing the development of amyloi-
dosis.
The use of fullerenes for gene transfer will be
described later. Now we will dwell on publications
concerning the interaction between fullerenes and
nucleic acids which was studied using molecular dynam-
ics simulations. It was shown that the nanoparticle
binds to the minor grooves of double-stranded DNA
(dsDNA) and triggers unwinding and disrupting of the
DNA helix, which indicates that C60 can potentially
inhibit the DNA replication and induce potential side
effects.
The interaction of fullerene C60 with RNA occurs in
different fashion. Namely, C60 only binds to the major
grooves of the RNA helix, which stabilizes the RNA
structure or transforms the RNA configuration from
stretch to curl.298 Also, atomistic molecular dynamics
simulations showed that fullerenes strongly bind to
nucleotides despite the hydrophobic nature of C60 .
Binding of C60 to ssDNA causes significant deformation
of nucleotides.299
In an attempt 300 to understand the nature of the
interaction between C60 and the Watson – Crick base
pairs it was found that C60 forms stacking complexes
with nucleobases and base pairs. The strength of the
interaction of nucleobases with C60 is as follows:
G>C>A>T>U, while the complex of fullerene
C60 with the GC base pair is stronger than with the
AT base pair.300 However, practical value of these data
remains unclear since lipophilic fullerene C60 can hardly
be delivered to DNA or RNA through all membranes
and cytosol in the living organism.
In 2009, the first complex of fullerenol C60(OH)24
with DNA was synthesized and its fluorescence enhance-
ment was reported.301 Fullerenol binds strongly to the
phosphate backbone of native dsDNA and to base pairs
within the major groove of sodium salt of dsDNA.
Water-soluble fullerenols could bind to lambda DNA
and remarkably improve the DNA stability against
thermal degradation in a dose-dependent manner.302
And finally, why waste time on trifles, taking the
molecules of proteins and nucleic acids separately, when
we can take them all together in the form of a viral
particle?
A fullerene derivative was covalently attached to
Cowpea mosaic virus and bacteriophage Qb virus-like
particles, which are examples of naturally occurring
viral nanoparticles (VNP). Two different water-soluble
conjugates, VNP-C60 and VNP-PEG-C60 , were prepared
and it was shown that the attached fullerene moiety did
not inhibit the cellular uptake of dye-labelled VNP-
PEG-C60 complexes VIII (Fig. 16) in a human cancer
cell line.303 This offers new prospects for the design of
novel therapeutic strategies based on various delivery
systems.
Fullerenes as vehicles in drug delivery systems. High
lipophilicity of fullerene molecules make them useful
and sometimes irreplaceable, as vehicles in drug delivery
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Figure 16. Viral nanoparticle conjugated to fullerene derivative PEG-C60 (VIII).303
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systems and as gene transfection agents. Initially, it was
a system for targeted delivery of photosensitizers to
DNA. An acridine residue attached to the nitrogen
atom of aziridinofullerene was used as a vector. Acri-
dine can intercalate between the pairs of nitrogen bases
in a DNA molecule, thus immobilizing the fullerene core
(ROS generator) near the target.304 A conjugate of
fullerene C60 with a 14-mer oligonucleotide capable of
binding to a ssDNA and fixing the fullerene core about
DNA was also synthesized.305 To increase the specificity
of binding, fullerene derivatives containing a moiety
capable of binding to the minor groove of DNA were
synthesized.306
A fullerene-containing polyacid prepared from
6-aminohexanoic acid and fullerene C60 in basic con-
ditions can form ion pairs with hexamethonium. As a
result, the highly polar molecule of peripheral acetylcho-
line receptor can penetrate into central nervous system
(CNS), which is evident from the ability of the complex
to block the central effects. Thus, fullerene C60 deriva-
tives can be used as vehicles in systems for polar drug
delivery to CNS.307
The ability of fullerene moiety to act as a vehicle
increases significantly upon modification of the fuller-
ene core with polymeric addends. In this connection,
mention should be made of a dendrimer derivative of
C60 , AF-1, where the fullerene core is modified with a
Newkome-like dendrimer unit containing 18 carboxyl
groups and five dodecyl malonate residues which are
positioned octahedrally to the dendrimer.308 This com-
pound can self-assemble to form spherical nanostruc-
tures referred to as ‘buckysomes’ } of size 100 – 200 nm
in water.309
Empty buckysomes are not cytotoxic. The cellular
internalization of buckysomes was confirmed using a
hydrophobic fluorescent dye, which allowed one to use
these systems as nanocarriers for anticancer drug pacli-
taxel. The suppression of MCF-7 breast cancer cell
growth by the paclitaxel-embedded buckysomes demon-
strates the possibility of using AF-1 as a vehicle for
drug delivery systems.
Yet another dendrimer-like fullerene-based vehicle
C60 – PEI – FAc (FAc is folic acid) was obtained via
cationic polymerization of aziridine on the surface of
C60-NH2 and subsequent encapsulation of C60 – PEI
with FAc through an amide linker. The resulting den-
drimer had the outer layer of FAc molecules which
provided targeting. The drug delivery system was pre-
pared by conjugating docetaxel (DTX) to C60 – PEI –
FAc.
Compared to free DTX, the tumour-targeting drug
delivery system could efficiently cross cell membranes,
lead to more apoptosis and afford higher antitumour
efficacy in cultured PC3 cells in vitro. Furthermore, in
an in vivo murine tumour model, C60 – PEI – FA/DTX
afforded higher antitumour efficacy than free DTX
without obvious toxic effects to normal tissue.310
An example of a targeted drug delivery system based
on polynucleotides is provided by a conjugate of trima-
lonic acid-modified fullerene C70 (TF70) with an
aptamer named R13. It significantly enhances the PDT
efficiency of TF70 against A549 lung cancer cells. The
TF70-R13 conjugate is preferably localized in lysosomes
and can produce intracellular ROS that efficiently kill
cells under illumination.311
One more approach to designing delivery systems is
based on the concept of a modular carrier system. The
system employs diverse units or modules: a therapeutic
unit, an addressing unit (e.g., an antibody) which serves
to direct the drug to its target, and a multiplying unit
which increases the number of biologically active moi-
eties the system can carry. The role of the fullerene-
based multiplying unit can be played by, e.g., a [5 : 1]-
fullerene hexa-adduct.312 It has five malonate spacers
capable of binding two therapeutic units (photosensi-
tizer pyropheophorbide-a; a total of ten units) each, and
a longer malonate spacer conjugated to the addressing
unit (monoclonal antibody rituximab). It was shown
that such a modular delivery system is useful for PDT
and can potentially be used in any therapy in which a
high selectivity and affinity for the target is required.312
The lipophilicity of fullerene core can be used to
design compositions capable of penetrating lipophilic
barriers. Indeed, amphiphilic lipophilic derivatives
C60C(COOH)2 {(3
0H-cyclopropa[1,9](Ih-C60)[5,6]fullerene-
30,30-dicarboxylic acid} and C60C[COO(CH2)4SO2Na]
{sodium salt of di(4-sulfoxybutyl)-30H-cyclopropa[1,9](Ih-
C60)[5,6]fullerene-3
0,30-dicarboxylate} were used to trans-
fer arginine-rich cell-penetrating peptides like oligoargi-
nines across bilayer membranes.313, 314
Not only drug delivery systems, but also gene trans-
fection agents can be designed on the basis of fullerenes.
The ‘two-handed’ fullerene derivative IX was the first
representative of a new class of artificial vectors for
gene transfection.
This compound binds duplex DNA and transfers it
into cells, causing the cells to acquire the ability to
express novel genes. Upon complexation with the full-
erene, the plasmid containing a green fluorescent pro-
tein (GFP) reporter gene is taken up by the cultured
cells through phagocytosis and then the gene is
expressed in these cells.212, 315, 316
Efficient in vitro transfection was achieved using two
positively charged derivatives of fullerene C60, namely,
an octa-amino derivative Xa and a dodeca-amino deriv-
ative Xb (Fig. 17).317 It was found that a higher positive
charge of the fullerene derivatives was a dominant
physical attribute necessary for optimal ratio of
C60/DNA structural features leading to increased trans-
fection efficiency and that aggregation is the major
factor that negatively affected the cytotoxicity profiles
of the C60-vector/DNA complexes. This means that the
compound forms supramolecular complexes with DNA-
type ion pairs, which are transported into the cell more
efficiently than the gene itself.
Theranostics and theranostic agents. Design of thera-
nostic agents is yet another field of application of
fullerene derivatives that is closely related to the devel-
opment of delivery systems. It is nanomedicine that
combines two active principles, therapeutic and diag-
nostic, in a single particle. Theranostic tools are often
developed using polymer platforms.318 And, of course,
efforts to integrate polymers and carbon nanostructures
for the design of theranostic agents are underway.319, 320}From ‘buckyball’ and ‘liposomes’.
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Fullerenes can be treated as nanoparticles that pro-
vide a lot of possibilities for combining the two princi-
ples mentioned above in the same molecule. They are
very suitable as basis or auxiliary units in the design of
theranostic tools. The most remarkable is the fact that
fullerene-based theranostic agents can be single mole-
cules rather than nanoparticles [e.g., a methano-C60
derivative with hydrophilic spacers covalently tethered
to two doxorubicin (DOX) units, conjugate XI]
(Fig. 18).321
Since highly effective anticancer drug DOX possesses
strong absorption and fluorescence in the visible region,
incorporation of two DOX units into the fullerene core
enables the tracking of DOX-containing conjugates by
optical techniques. It was found that conjugate XI was
distributed mostly in the cytoplasm, which is signifi-
cantly different from free DOX molecules predomi-
nantly accumulated in the cell nucleus.322
One more theranostic nanoparticle was designed on
the basis of fullerenol C60(OH)24 . Tumours injected
with fullerenols were imaged using photoacoustic
tomography and photothermally treated with a near-IR
laser. As a result, the tumour size decreased by 72%
within two hours of treatment and only a blister was
visible after 20 h.323, 324
Theranostic tools on the basis of EMFs can be
developed with relative ease. For example, a conjugate
of a derivative of the EMF Gd@C82 , namely,
Gd@C82O6(OH)16(NHCH2CH2COOH)8, with the anti-
body of GFP (anti-GFP) presents a model for tumour-
targeted imaging contrast agent based on EMFs.325
A macromolecular MRI contrast agent Gd-DTPA-
HSA (DTPA is diethylenetriamine pentaacetate) can be
modified by trimalonate C60[C(COOH)2]3 . The
Gd-DTPA-HSA-C60 conjugate exhibits a maximum
relaxivity reported so far, which is comparable with the
theoretical maximum.326 Being included in the same
molecule, HSA and carboxylfullerene exhibit a synergis-
tic effect. Since two modalities, therapeutic (fullerene
core as photosensitizer) and diagnostic (gadolinium as
MRI contrast agent), are present in the same composi-
tion, it can be considered as a theranostic system.
Theranostic agents containing radioactive atoms can
also be designed on the basis of corresponding EMFs.
An example is provided by a conjugate 177Lu-DOTA-
f-Gd3N@C80 with a TNT-EMF (as MRI contrast agent)
and a 177Lu complex with DOTA (as therapeutic agent).
For the imaging capabilities of this theranostic agent,
see Ref. 327. Regarding therapeutic efficacy in vivo, see
Ref. 328.
New theranostic molecules can also be prepared on
the basis of a nanoplatform from 3-aminophenylboronic
acid functionalized with up-conversion nanoparticles
(APBA –UCNPs) and hyaluronated fullerene
(HA – C60) via a specific diol-borate condensation. In
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this conjugate, the two specific ligands provide syner-
gistic targeting effects, high targetability, and hence a
dramatically increased uptake of the nanoplatform by
cancer cells. High yield of 1O2 due resonance energy
transfer between APBA-UCNPs (donor) and HA7C60
(acceptor) also favours effective therapy. The nanoplat-
form shows a great potential for highly selective
tumour-targeted imaging-guided PDT.329
‘Wrapping’ in PEG of iron oxide nanoparticles
(IONP) and fullerene C60 enhances the photodynamic
effect of fullerenes. Hematoporphyrin monomethyl ether
(HMME), a new photodynamic anticancer drug, con-
jugated to C60 – IONP – PEG forms a C60 – IONP – PEG/
HMME drug delivery system, which demonstrated an
excellent magnetic targeting ability in cancer therapy.
Since C60 – IONP – PEG can be further used as a T2-
contrast agent for in vivo MRI, it was concluded that
the C60 – IONP – PEG/HMME system has a great poten-
tial for cancer theranostic applications.330
It is the impression that EMFs were designed by
nature as a basis for contrast agents. In these molecules,
the carbon cage protects a metal atom (or a group of
atoms) from the external environment. Therefore, the
encapsulated metal atoms do not interact with the bio-
logical environment, do not take part in any biochem-
ical reactions in the body and are thus nontoxic.331 The
state-of-the-art in the application of EMFs in biology
and medicine has been considered in a comprehensive
review.332 Two more reviews are also available.320, 333
Endometallofullerenes exhibit unique properties that
differ distinctly from those of empty fullerenes because
of the presence of metal atoms and hybridization effects
as a result of electron transfer. In some details, they are
similar, however. For example, the reactivity of carbon
atoms of the EMF core is quite sufficient to obtain
water-soluble derivatives, and the set of possible EMF
derivatives coincides with that of the ‘empty’ fullerene
derivatives. For instance, the application of
[Gd@C82(OH)22]n can repair the functions of injured
liver as well as kidney tissue,334 i.e., there is a very good
correlation of the effect of [Gd@C82(OH)22]n with that
of fullerenol C60(OH)24 in vivo.335
Magnetic resonance imaging is one of the most
common techniques for diagnostic examination using a
magnetic field and pulses of radiofrequency energy to
visualize organs and structures inside the body. The
visibility of the internal body structures in MRI can be
drastically improved using contrast agents, which can
change the proton relaxation times in tissues and body
fluids.
To this end, organic chelates of rare-earth metals
with paramagnetic properties (in particular, gadolinium
chelates) are used in clinics.336 Unfortunately, inside the
body, these chelates partially release highly toxic Gd3+
ions. In this case, the cage protection of the toxic metal
ions in EMFs is several times more effective.
Thus, metal ions (e.g., gadolinium ions) can be
shielded from the chemical activity within the body
and the unwanted release of metals can be minimized
or even avoided. The large surface area of the fullerene
core also enables multiple hydrophilic functionalizations
and the attachment of some tissue-targeting ligands. All
these features provide opportunities for the application
of endometallofullerenes Gd@Cn in MRI.333
To date, various water-soluble derivatives of Gd@Cn
systems have been synthesized and investigated for their
imaging properties. The archetypes of these species are
hydroxylated EMFs Gd@C82(OH)x (Ref. 337) and
Gd@C60(OH)x .338 It was mentioned that all the repor-
ted systems including Gd@C60[C(COOHyNa17y)2],339
Gd@C82(OH)6(NHC2H4SO3H),332 and
Gd@C82O6(OH)16(NHC2H4CO2H)8 (AAD7Gd@C82 ,
Ref. 340) generally show much higher relaxivities than
Gd7DTPA.
Due to the high stability, high relative yield, and
encapsulation of three Gd3+ ions per molecule,
TNT-EMFs have certain advantages, e.g., high contrast.
Among related EMFs, a high 1H NMR relaxivity was
shown for hydroxylated Gd3N@C84(OH)x .341 Mixed-
metal metallofullerenes simultaneously containing gado-
linium and lutetium or holmium and lutetium and
having the composition Lu37xAxN@C80 (A=Gd, Ho;
x=0 – 2) were proposed for X-ray tomography and
MRI multifunctional diagnostic products.342
Not the last role in the design of biologically accept-
able compositions with EMF belongs to polymers. For
example, the system Gd3N@C80[DiPEG(OH)x] with two
PEG units at the exohedral carbon atom shows the
highest relaxivity among the EMF derivatives used as
MRI contrast agents.343 Endometallofullerenes are suit-
able for the design of not only contrast agents for MRI,
but also other methods of investigation. For example,
an atherosclerotic-targeting contrast agent can be pre-
pared on the basis of Gd3N@C80.344
Radiopharmaceuticals based on EMFs. Endohedral
metallofullerenes with encapsulated radioactive metal
atoms (166Ho, 177Lu) are expected to act as radiotracers
or as delivery systems for brachytherapy. A biodistribu-
tion study of 166Hox@C82(OH)y demonstrated the feasi-
bility of using this compound as a radiotracer.345 A
significant advantage of such a strategy is elimination of
the undesired toxicity of radionuclides that might be
leaked from their conventional complexes.
Recently, radioactive EMFs for radioimmunotherapy
of cancer have been developed.346 It was also shown
that a conjugate of radiolabelled cluster
177LuxLu(37x)N@C80 with the 1L-13 peptide and a
fluorescent tag (tetramethyl-6-carboxyrhodamine,
TAMRA) can be used for radiotherapeutic and radio-
diagnostic applications.327
Endometallofullerenes and chemotherapeutic pharma-
ceuticals. Anticancer drugs can also be designed on the
basis of EMFs containing no radioactive atoms. In
particular, polyhydroxylated EMF Gd@C82(OH)22
exhibits high antineoplastic activity in mice in a dose
of 1077 mol kg71.347 This high antitumour activity
belongs to the [Gd@C82(OH)22]n particles about 22 nm
in diameter in saline. Being practically nontoxic, as
confirmed by in vitro and in vivo tests, these particles
inhibit tumour growth by interfering in the processes of
tumour invasion in normal muscle tissue.
In other words, the Gd@C82(OH)22 nanoparticles do
not kill the tumour cells directly, which is in sharp
contrast to conventional antineoplastic chemicals. The
mechanism of antitumour effect has not yet been fully
clarified. According to more recent studies, the actual
functions of the Gd@C82(OH)22 nanoparticles might
involve improving immunity (for details, see Ref. 348).
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Some other interesting properties of Gd@C82(OH)22
nanoparticles have been documented.349 It was also
assumed that, having fullerene derivatives with appro-
priately modified surface, the dream of the oncologist to
design a highly potent but low toxic anticancer drug can
be realized.347
Fullerene distribution and metabolism. Two essential
parameters of all pharmaceuticals are their pharmaco-
kinetic and metabolic properties. The dynamic distribu-
tion of fullerenes in the body is influenced by several
factors including the particle size, the type and degree of
functionalization and the administration pathways.
Orally administered 14C-labelled fullerene C60 is
excreted primarily in feces. Unlike this, C60 injected
intravenously is cleared from the blood circulation
rapidly, accumulates mainly within the liver, remains
there for a long time, and then is removed slowly from
the liver (nearly completely 13 days after injection). All
these results suggest that the liver is a potential target
for fullerene accumulation.202, 350, 351
Certainly, much more is known about the distribu-
tion of EMFs in the body, since their monitoring is
easier. Therefore, there is more data available on their
fate in the body compared with nonradioactive full-
erenes. After administration of 140La@C82 to rats no
more than 20% of the total radioactivity was eliminated
in 24 h, and the remaining 80% was accumulated in the
liver, blood, and brain.352 A more detailed study of the
166Hox@C82(OH)y distribution in rats showed that the
agent was distributed throughout the entire body, except
for tissues with limited blood flow, as early as 1 h after
the tail vein injection.345
The concentration of 166Ho increased only in the
liver and bone from 1 to 4 h, especially in bone, which
subsequently displayed a slight increase in the concen-
tration over a period of 48 h. These results were
consistent with those of a biodistribution study of
[Gd@C82(OH)22]n particles, which were delivered to
almost all observed tissues but accumulated mostly in
bone. This suggested that the fullerene cage was not
destroyed in organisms and that the encapsulated Gd3+
was well protected in the cage.
The concentration of gadolinium in the brain was
close to the baseline, thus suggesting that the
[Gd@C82(OH)22]n nanoparticles could not pass through
the blood – brain barrier.334 Similar results obtained in
the biodistribution studies of C60(OH)x and C82(OH)y
showed that the biological properties would not be
expected to change upon encapsulation of metal atom
in the fullerene cage.320
Toxicity. No one has observed any manifestations of
the acute toxicity of fullerenes.2, 202, 353 – 355 The widely
advertised data in Ref. 356 is negligible (see Refs 357
and 358). Only some derivatives are toxic.359, 360 At the
same time, fullerenol C60(OH)24 showed no cytotoxicity
up to its limit of solubility.320
Chronic toxicity, especially in connection with the
established accumulation of fullerenes in the liver,361
has not been studied well enough. It was demonstrated
that fullerene C60 can react in vivo inside liver cells with
vitamin A, thereby undergoing in vivo a Diels – Alder-
like reaction.362 There is still no definitive answer to the
question of whether fullerene metabolizes, and how. All
these uncertainties cause some circumspection in the use
of fullerenes in drug design.
III.4. Sensors and actuators
Unique features of fullerene derivatives have been used
in the development of new sensors for biological and
medical applications.363 – 365
Two types of polymer films, viz., a polythiophene
film and a didodecyldimethylammonium bromide
(DDAB) one, were studied by electrochemical techni-
ques.363 Both films were modified with the EMF
Dy@C82 . Preliminary results on the redox properties
and sensor applications of the modified films were
described. It was found that Dy@C82 in the DDAB
membrane promotes the encapsulation of hemoglobin
through the attractive interaction, and hemoglobin can
catalyze the reduction of Dy@C82.
Sharma et al.364 presented the conception of molec-
ularly imprinted polymer (MIP) film for adenosine-5 0
triphosphate (ATP) using reductive electropolymeriza-
tion and fullerene derivatives. ATP plays a key role in
the energy turnover in a living cell. It transports meta-
bolic energy and, therefore, can be considered a bio-
logical ‘energy unit’. The use of fullerenes with attached
recognizing groups may be useful in the sensing field
because the presence of these groups in the fullerene7
MIP film improves electrochemical characteristics of the
film by decreasing its resistivity.
Three types of fullerene derivatives were employed as
functional monomers, namely, N-phenyl-4-(fullero-N-
methylpyrrolidin-2-yl)benzamide, 4-(fullero-N-methyl-
pyrrolidin-2-yl)benzoic acid and 4-(fullero-N-methylpyr-
rolidin-2-yl)uracil. Amide groups were used for
complexation with the phosphate moieties of ATP. The
presence of the ribose vicinal diol in the ATP molecule
allowed one to use a carboxy monomer of C60 as one
more functional monomer for imprinting. The uracil-
containing functional monomer can form hydrogen
bonding due to complementary base pairing of adenine,
adenosine and ATP. The hydrogen bond involved in this
pairing is a directional secondary valence force com-
pared to other noncovalent bonds, such as electrostatic,
van der Waals, and hydrophobic interactions. This
feature was used in the last step of the MIP7ATP film
preparation. The complex of ATP with the fullerene
derivatives is schematically shown in Fig. 19.
The ATP template was present in the MIP – ATP film
due to electropolymerization.364 The subsequent absence
of this template after extraction proved the formation of
the pre-polymerization complex in solution, and then
deposition of the polymerized molecular imprint. This
fullerene based MIP7ATP film was integrated with two
different transducers, an Au-film electrode of a quartz
crystal resonator and the Pt electrode, for fabrication of
piezoelectric microgravimetry and the capacitive impedi-
metric chemosensor, respectively.
A nanocomplex of glucose oxidase (GOD) with
hydroxylated fullerene immobilized on a glassy carbon
electrode and protected with a chitosan membrane
(Fig. 20) was studied.365 The possible secondary struc-
ture and the catalytic properties of GOD were charac-
terized by different experimental methods including
UV/Vis absorption spectrometry, TEM and circular
dichroism.
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A possible application of the modified electrode is a
third-generation glucose biosensor with high sensitivity
and selectivity. An additional benefit of these methods
is the fact that conformation of GOD is maintained.
Consequently, the catalytic properties of the modified
GOD are similar to those of the native GOD.
Practical application of this method is complicated
by the fact that real samples (e.g., blood) may contain
high concentrations of other components (carbon diox-
ide, bicarbonate, hemoglobin, plasma proteins, phos-
phate). Some of them can cover the electrode surface
or block channels in the chitosan membrane and thus
seriously affect the detection results. However, the
authors believed 365 that the undesired effects may be
eliminated or strongly reduced by diluting the blood
samples to be analyzed.
A topical application field of polymers is to use them
in the design of actuators. Stimuli-responsive polymer
actuators are smart materials capable of responding to
external stimuli and performing large-deformation
mechanical work. This is especially important when
creating artificial muscle. A distinctive feature of actua-
tor materials is the possibility to change their mecha-
nical properties under the action of an external field
(typically, electric field). In practice, an actuator should
be able to provide a large actuation under low voltage.
Due to its electrical properties, fullerenol allows
improving the mechanical properties of polymer actua-
tors. Also, an important feature of the use of fullerenol
in main actuator systems is the water solubility of this
fullerene derivative. A number of studies on the appli-
Pd
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Pd
ATP template (1)
C60-amide
monomer (2)
C60-uracil
monomer (4)
Polymerization initiator
C60-COOH
monomer (3)
Figure 19. Simplified possible structure of the pre-polymerization complex of ATP (1) with functional monomers: N-phenyl-4-(fullero-N-
methylpyrrolidin-2-yl)benzamide (2), 4-(fullero-N-methylpyrrolidin-2-yl)benzoic acid (3), 4-(fullero-N-methylpyrrolidin-2-yl)uracil (4) and
Pd(OAc)2 cross-linker.364
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50 nm
Figure 20. Possible structure of glucose oxidase complexes with
hydroxylated fullerenes (a), a TEM image of a chitosan membrane
with nanoparticles of these complexes (b) and a schematic structure
of a glassy carbon electrode modified with nanoparticles of the
complexes and coated with chitosan membrane (c).365
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cation of fullerenol-modified polymers in the design of
actuators are available.
Kyokane and co-workers 3667368 studied actuators
based on fullerenol-doped PUE.
Monomorph actuators were fabricated 367 from a
PUE film and two kinds of metal electrodes of different
thickness. The working voltage of the PUE actuator
(film 200 mm thick) was more than 1 kV, which was high
for the commercial device used. The monomorph actua-
tors were doped with fullerenol (0.1% and 0.25%) in
order to provide large bends at low voltage. To under-
stand the results obtained, a fullerene-modified PUE
was studied. The bend of the PUE actuator doped with
fullerenol was independent of the thickness of the
metallic electrode and of the electrode material. Since
the PUE films contain many polar groups in the soft
segment, it was assumed that the bend of the actuator
occurred when the molecular chain was stretched due to
orientation of the polar groups in electric field. Also,
the bend of the fullerenol-doped PUE actuators
increased with increasing fullerenol concentration and
reached a maximum value at 0.25%. At 300 V and
0.25% of fullerenol, the fullerenol-doped actuator was
found to bend about three times larger than undoped
films. The bend of the C60-modified PUE actuator was
smaller that that of the pure PUE actuator. Thus, the
best results were obtained for the fullerenol-doped
actuator. The large bend of this actuator was due to
the crosslinking density that increased in the PUE films
due to combination of hydroxyl groups of the star-
shaped fullerenol which were incorporated into hard
segments. That is, the apparent number of polar groups
in the soft segment increased with increasing the cross-
linking density of the PUE films. Other improved
properties include an increased dielectric constant and
induced e.m.f. of the fullerenol-doped films compared to
other PUE films.
In a continuation of research on actuators based on
fullerenol-doped PUE films Kyokane and co-workers.368
showed that the bend, the forced actuation, and the
induced voltage increased with the increase in the
number of hydroxyl groups in fullerenol. Also, a piezo-
electric effect was found in the fullerenol-doped PUE
films in contrast to the undoped films.
New nanofibrous actuators based on electrospun
cellulose acetate with fullerenol additives (0.1% or
0.5%) were developed.369 The morphology of nanofi-
brous membranes resembled the porous structure of
extracellular matrix of natural muscles. A chemical
interaction between the hydroxyl groups of fullerenols
and carboxylate groups was revealed by FT-IR spectro-
scopy. Using X-ray diffraction and differential scanning
calorimetry, it was shown that the degree of crystallinity
and labile bonding of polymer chains to the fullerenol
surface increased and led to the formation of novel
crystalline structures. Actuation tests showed more
than a threefold increase in the tip displacement even
at minute concentrations of fullerenol. This improve-
ment of actuation performance was caused by super-
position of three effects, namely, higher degree of
crystallinity, piezoelectric behaviour of cellulose acetate,
and electrostrictive effect of fullerenol. The results
obtained demonstrate that minute concentrations of
fullerenol significantly influence the structural and elec-
troactive properties of biocompatible nanoporous actua-
tors based on cellulose acetate. Changes in mechanical
properties of the modified membranes were also
observed. Adding 0.5 mass% of fullerenol to cellulose
acetate fibres increased the tensile strength from 1.6
MPa to 2.75 MPa, i.e., by more than 75%. Undoubt-
edly, this effect is a result of interactions between the
cellulose acetate moieties and fullerenol molecules. Full-
erenol is a zero-dimensional nanosized filler; its particles
are smaller than the length scale of the cellulose acetate
polymer chain. Therefore, some fullerenol molecules
may be physically entrapped in the free volume, which
leads to labile bonding of cellulose acetate chains with
the fullerenol surface, resulting in a substantial increase
in the tensile strength. The increase in tensile strength
was also accompanied by a drastic decrease of nearly
100% in elongation at break, indicating that the addi-
tion of fullerenol increases the stiffness of the mem-
branes.
Electroactive artificial muscles based on fullerenol
and sulfonated polyetherimide (SPEI) were studied.370
Being an electroactive polymer, SPEI is a good candi-
date material for electromechanical actuators because of
its high mechanical strength, thermal stability, cost
efficiency, stable film-forming properties, reasonably
high water uptake and ion-exchange capacity.
It was established that incorporation of fullerene
(0.5 mass%) into the polymer led to fundamental
changes in proton conductivity and water uptake.
These properties are vital parameters for high-perform-
ance actuators. The fullerenol7SPEI actuators showed
larger bending deformation under the action of har-
monic and step inputs as compared to the pristine
SPEI actuator. Moreover, the straightening-back phe-
nomenon, a critical drawback of ionic polymer actua-
tors, was not observed for the fullerenol7SPEI
actuators. The movement of hydrated fullerenol mole-
cules in the nanoscale ionic channels of the fullerenol7
SPEI membranes results in much larger bending
deformation under the action of electric field. Also, it
is important that fullerenes and SPEI are biocompatible
and eco-friendly, so these fullerenol7SPEI actuators
may appear to be promising candidates for the use in
biomedical devices, artificial muscles and biomimetic
robots.
Panwar et al. 371 fabricated and studied composite
membranes for ionic polymer metal composite (IPMC)
actuators. The membrane material contained fullerenol
(0.1 mass%, 0.3 mass% and 0.5 mass%), polyvinyli-
dene fluoride, PVP and polystyrene sulfonic acid. It
was established that incorporation of fullerenol into
the membrane significantly and rapidly improved the
function of the IPMC actuator at d.c. and a.c. voltages
of 0.5 – 1.5 V. For comparison, experiments with cellu-
lose acetate7fullerenol 369 and SPEI7fullerenol mem-
branes 370 required a voltage of 3 and 5 V, respectively.
The largest normalized tip displacement was obtained at
d.c. voltages of 0.5 – 1.5 V for the IPMC actuator
containing 0.3 mass% of fullerenol and characterized
by highest capacitance and electric current. The water
uptake, proton conductivity, and tensile strain of the
fullerenol-doped membranes were higher than those the
untreated membranes and led to an increase in the
electric current, capacitance and tensile strain of the
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IPMC samples. Improved hydrophilic behaviour and
proton conduction in the fullerenol-containing compo-
site membrane were confirmed by X-ray photoelectron
spectroscopy and impedance spectroscopy. Therefore,
the fullerenol-doped IPMC actuators provide fast and
large actuation at d.c. and a.c. voltages of 0.5 – 1.5 V.
It was assumed 371 that the enhanced and fast actua-
tion performance of these IPMC actuators can be very
useful for utilizing them in active guide wires and
swimming micro-robots applications.
III.5. Optoelectronics and optical-limiting materials
The main idea of using fullerene derivatives in optoelec-
tronics is the mixing of fullerene derivatives and con-
jugated polymers to obtain organic semiconductor
materials that can be used for new optoelectronic devi-
ces. A typical structure of an optoelectronic device
comprises a conjugated polymer acting as an electron
donor and a fullerene-containing material acting as an
electron acceptor. Absorption of light leads to gener-
ation of excitons that encounter the donor/acceptor
interface and dissociate. Exciton dissociation is followed
by electron transfer from the polymer to the fullerene
cage and generation of photocurrent.
One of the famous methanofullerenes used for this
purpose is PCBM. Itskos et al.372 systematically studied
the optical properties of pristine samples as well as
binary and ternary blends of a conjugated polymer
(P3HT), fullerene derivative (PCBM) and colloidal
nanocrystals (oleic acid capped PbS quantum dots)
using a combination of steady-state and time-resolved
optical methods. Steady-state absorption measurements
revealed a modest increase in the red and near-IR light
harvesting efficiency upon addition of the quantum
dots. Photoluminescence experiments performed in the
emission regions of P3HT and quantum dots showed
partial quenching of the photoluminescence of the
blends compared to the emission of the pristine films.
Emission quenching in the polymer region was attrib-
uted to re-absorption by the quantum dots and to
electron transfer mostly to PCBM and, to a lesser
degree, to the nanocrystals. On the other hand, emission
of the quantum dots was predominantly quenched due
to electron transfer to PCBM and/or to hole transfer to
P3HT. Ultrafast transient absorption measurements
revealed a variety of relaxation pathways of the photo-
generated P3HT species in the blends. At shorter times,
relaxation in all samples was dominated by linear hot
exciton relaxation effects. At longer times, long-lived
components associated with charge-transfer excitons
were observed. The formation of such species occurred
efficiently in the samples containing a significant
amount of P3HT and PCBM, but the process was
quenched in the P3HT sample doped with quantum
dots and in the pristine P3HT film. At short probe
wavelengths corresponding to the ground state of the
P3HT singlet exciton, a long-lived photobleaching of the
state was observed in the blends containing quantum
dots. Overall, both steady-state photoluminescence
experiments and transient absorption measurements
showed that interfacial charge transfer processes
occurred more efficiently at the fullerene/polymer and
fullerene/nanocrystal interfaces compared to the poly-
mer/nanocrystal interfaces. Thus, doping with fullerene
seems to facilitate exciton dissociation in the ternary
blends studied.
The possibility to use poly(N-vinylcarbazole) (PVK)
doped with PCBM to detect UV light was demon-
strated 373 in relation to a well understood device struc-
ture for organic light-emitting diodes and organic
photovoltaics with a high work function anode and a
low work function cathode. The chemical structure of
PVK as well as the device architecture are shown in
Fig. 21. It was established that PVK:PCBM devices
generate a substantial open-circuit voltage upon illumi-
nation with UV light. The UV sensing potential of this
system was confirmed by UV/Vis spectroscopy in addi-
tion to the importance of the substrate and anode
material. Different substrate materials (quartz or nor-
mal glass) in the devices led to different results under
illumination. In the case of quartz glass, devices per-
formed better. The limiting factors for the performance
of the devices include the anode material (indium-tin-
oxide) and possible shunts in the active layer.
Practical application of polymer – fullerene derivative
films in electronic devices and solar cells requires that
the heat resistance problem be solved. Heating can lead
to the formation of large clusters of fullerene materials
in the films, which can cause poor phase separation in
the donor/acceptor mixed films, thus influencing the
performance of the devices. To improve the thermal
stability of the polymer – fullerene derivative materials,
it was proposed 374 to use a fullerene derivative contain-
ing an adamantane group instead of traditional fullerene
materials like PCBM. Incorporation of the adamantane
unit into polymers significantly improved their stability
including enhancement of heat resistance and glass
transition temperature.
Liao et al.374 systematically studied [6,6]-phenyl-C61-
butyric acid 1-adamantylmethyl ester (PC60BAd) in
P3HT:PC60BAd films as well as its optoelectronic prop-
erties and thermal stability. In an organic field-effect
transistor device, the electron mobility of PC60BAd was
found to be as high as 0.01 cm2 V71 s with a high on-off
(Ion/Ioff) ratio of 4.96106, which is useful for logic
device applications. The PCE of the optimized
P3HT:PC60BAd organic photovoltaic devices was
found to reach a value of 3.31%. The active layer of
P3HT:PC60BAd was found to exhibit superior thermal
stability over that of P3HT:PCBM. After heating at
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Figure 21. The chemical structure of poly(N-vinylcarbazole) (a)
and the organic light-emitting diode architecture (b).373
PEDOT is poly(3,4-ethylenedioxythiophene) and PSS is poly(styr-
ene sulfonate).373
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150 8C for 20 h, the P3HT:PC60BAd device still showed
a PCE of 2.44%, thus demonstrating the applicability of
PC60BAd.
Yet another interesting direction of methanofuller-
ene applications is the surface modification of semi-
conductor nanocrystals. Inorganic colloidal
nanocrystals possess necessary properties for being
used in optoelectronics as active elements of light-emit-
ting diodes and photovoltaic devices. These applications
require that the surface of the nanocrystals be thor-
oughly controlled because the ligand shell is important
to prevent aggregation. Many crucial features of the
nanocrystals, such as solubility, reactivity, processabil-
ity and, most importantly, electronic properties with
direct effects on conduction and optical activity can be
controlled by tuning the surface design.
Binding yet another fullerene derivative, 3,4-
dihexyloxyphenyl-C61-butyric acid (dPCBA), to PbS
and CdSe nanocrystals 375 is a new method of nano-
crystal surface modification using electroactive fullerene
derivatives. The occurrence of a ligand exchange reac-
tion was confirmed by UV/Vis spectroscopy, photolu-
minescence and time-resolved photoluminescence
measurements indicating photoinduced charge transfer
from the nanocrystals to dPCBA molecules. The cur-
rent – voltage characteristics of the complexes of dPCBA
with nanocrystals showed enhanced photocurrents due
to charge carrier transfer and a decrease in the potential
barrier between nanocrystals. This also indicated that
the complexes under study can be promising building
blocks for photovoltaic devices.
The self-assembly strategy was utilized 376 to form
monolayer structures. This approach increases the
potential of fabrication of electronic devices with
improved interfacial contact, and, therefore, it should
lead to enhanced electron transfer between the acceptor
and donor materials. Four water-soluble fullerene deriv-
atives, namely, methanofullerenes with phosphonate
groups attached to the C60 core were studied. Different
electrode substrates (indium-tin-oxide, Au and Si) with
specific anchoring groups (zirconium, cysteamine and
amino-silane) were used to form self-assembled mono-
layers. The conclusion about the formation of surfaces
was based on the results obtained by different exper-
imental methods including AFM, IR spectroscopy, con-
tact angle measurements and cyclic voltammetry (CV).
It was established by CV that the reduction potentials of
substituted methanofullerenes, both in solution and in
monolayer, were slightly higher than the formal poten-
tials of the redox reactions of fullerene C60 . The AFM
results showed that the fullerene molecules produce
surface features with an apparent height of about 2 nm.
The application of methanofullerenes in ultrafast
spectroscopic holography was proposed 377 taking cho-
lestanoxy methanofullerenes in luminescent polymers
from the polyphenylenevinylene family as examples.
These materials were studied in detail using tunable
non-degenerate four-wave mixing. The role of the meth-
anofullerenes was to enhance charge transfer in the
polymer systems, which is important for the holography
processes. The results of experiments demonstrated that
the potential holographic information processing den-
sity of these objects is up to 12 orders of magnitude
higher compared to other holographic nonlinear optical
materials. Using transient absorption spectroscopy, the
complex photoinduced index of refraction was deter-
mined in the photon energy range of 1 – 2.5 eV. Having
performed the Kramers – Kronig transformation of the
broadband photoinduced absorption spectrum, a reli-
able diffraction efficiency spectrum was obtained.
The possibility of fabricating new optical devices
based on poly(propylene carbonate) containing fullere-
nol C60(OH)n as terminal unit was demonstrated.378 The
material was obtained by copolymerization of propylene
oxide and CO2 using the Et2Zn – C60(OH)n catalytic
system. The emission spectrum of the material exhibits
an emission band with a few peaks in the UV region,
which are absent in the spectra of individual C60(OH)n
and polymer. Thus, C60(OH)n derivatives can be used as
new kinds of chemical sensors or other optical devices
due to the change in emission wavelength of the
C60(OH)n fragment in polymers.
The main goal of optical limiters is eye and sensor
protection from high-intensity laser pulses. It is known
that fullerenes possess excellent nonlinear optical-limit-
ing properties. However, the poor solubility of full-
erenes and poor adhesion between fullerenes and
polymers usually hinders their utilization in such devi-
ces. These difficulties can be avoided by functionaliza-
tion of fullerenes to give fullerenols or
methanofullerenes. In this direction, complexes of full-
erene derivatives with polymers were studied both in
solution (see, for example, Refs 379 and 380) and in
blends.381 – 384 We will focus on fullerene derivative –
polymer blends because the use of solid devices is
largely preferred for technical purposes due to greater
ease of handling compared to liquid solutions.
Multifunctional fullerenols were utilized in fullere-
nol – polymer composites,381, 382 with poly(styrene-co-4-
vinylpyridine) (PSVPy) and poly(styrene-co-butadiene)
being the polymer matrices. The optical-limiting proper-
ties of fullerenol were studied at 532 nm with nano-
second laser pulses. Compared to fullerene C60 ,
fullerenol showed a weaker nonlinear optical response,
which may be ascribed to the disturbance of the p-elec-
tron system of the parent C60 molecule due to multi-
functionalization. Polystyrene does not significantly
change the optical-limiting performance of the fullerenol
solution, while PSVPy containing 32 mol.% of vinyl-
pyridine slightly improves the optical-limiting perform-
ance of the concentrated fullerenol solution.
Nonlinear optical (NLO) absorption of a blend of
poly(3-octylthiophene) (P3OT) and a methanofullerene
was studied 383 using nanosecond laser pulses at wave-
lengths from 620 to 960 nm (1.3 – 2.0 eV) with [6,6]-
phenyl-C61-butyric acid cholesteryl ester ([6,6]-PCBCR)
as the methanofullerene. Solid films containing [6,6]-
PCBCR (1 : 1 by mass, approximately one acceptor for
every five repeating units of P3OT) were synthesized.
For comparison, pure methanofullerene films and pure
P3OT films were measured by the same technique as the
blend. Thick films (20 – 30 mm) for nonlinear optical
absorption experiments at off-resonant wavelengths
were cast from filtered solution onto fused silica sub-
strates. Thin films (0.1 – 0.2 mm) for measurements near
resonance and for the third harmonic generation experi-
ments were prepared by spin coating.
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Enhanced NLO optical absorption of the polymer7
methanofullerene blend was observed. Individual com-
ponents of the material did not demonstrate such an
effect. For instance, the NLO absorption of the blend
film at 760 nm enhanced by more than two orders of
magnitude compared to the films prepared from the
pure components. The high nonlinearity results from
efficient photoinduced intermolecular charge transfer
from the polymer to methanofullerene followed by
absorption in the charge separated excited state. It was
established that when pumped at 760 nm, the trans-
mitted energy saturates at an average fluence of approx-
imately 0.1 J cm72. The damage threshold was 15 mJ
pulse71 (*1 J cm72 in average fluence), above which
there was a permanent change in the linear transmission.
It was assumed 383 that NLO absorption of P3OT7me-
thanofullerene blends is high enough that the photo-
induced charge transfer films be promising as optical
limiters.
Nonlinear absorption and the optical-limiting prop-
erties of a ternary blend including a conjugated polymer
(electron donor), a fullerene (electron acceptor) and a
plasticizer were studied.384 The blends of MEH-PPV
and PCBM are well known to show efficient one-photon
induced charge carrier generation and have been studied
extensively as solar cell materials. However, these blends
have a poor optical quality, which restricts their utility
in optical-limiting devices. To solve this problem, a
plasticizer (dioctyl phthalate, DOP) was added to the
MEH-PPV – PCBM system. This made it possible to
obtain thick films (25 mm) of high optical quality. For
comparison, nonlinear absorption of the blend contain-
ing no methanofullerene (MEH-PPV –DOP) was meas-
ured. In the femtosecond regime, two-photon absorption
induced excited-state absorption of MEH-PPV domi-
nated the suppression, and a *10 dB of suppression
was observed for both samples with and without PCBM.
In the nanosecond regime, the suppression was
enhanced by the accumulation of absorbing charge
carriers over the long pulse duration and a contribution
of one-photon absorption to the carrier generation due
to a ground-state charge-transfer complex of MEH-PPV
and PCBM, especially at the shorter wavelengths
studied. The blend with the methanofullerene showed a
significantly reduced turn-on threshold and increased
suppression of 15 dB relative to the sample containing
no PCBM. Thus, the MEH-PPV – PCBM –DOP blend
showed stronger suppression than what had been
reported to date for organic optical-limiting materials
containing methanofullerenes in the 750 – 900 nm range.
IV. Conclusion
The applications of fullerenes and their complexes with
conjugated polymers as well as supramolecular com-
plexes of fullerenes are now extensive and diverse, and
fullerene-containing polymer compositions are impor-
tant tools for various fields. The medicinal chemistry
of fullerenes allows one to select the derivatives for the
desired biological effects and to perform fine tuning of
the structure, thus showing that fullerene derivatives
have already found their place in this area, similarly to
all other classes of organic compounds.
Recently, fullerene derivatives have been playing a
crucial role in the rapidly emerging field of organic
photovoltaics, stimulating research interest in under-
standing the physical processes that would help to
increase the performance of organic solar cells. It is
hard not to be captivated by the recent progress in
photovoltaic devices, with the improvements in the
efficiency when new functionalized fullerenes are used.
The PCE limit of 10% has now been surpassed,385 and
there are no doubts that this value is still far away from
the possible physical limit of organic solar cell perform-
ance.386
Intensive research is ongoing in both fundamental
and applied directions. First, it is important to get clear
understanding of physics of interfacial molecular proc-
esses involving donor and acceptor materials — exciton
dissociation, charge separation, and recombination. Sec-
ond, progress in organic solar cell performance is fuelled
by the creation of new fullerene acceptors with more
interesting properties and by the design and develop-
ment of new types of highly efficient devices.
The possibility of performing fullerene sensitization
of well-known oxide photocatalysts through a charge
transfer mechanism has met with a generous response
from researchers and led to great potential for many
photocatalytic applications. Fullerene derivatives
including particularly attractive biocompatible water-
soluble fullerenols allowed researchers to extend the
range of irradiation wavelengths corresponding to active
photocatalytic processes to the visible region.
This led to emergence of new application areas of
fullerenes, such as oxidative degradation of pollutants
(e.g., dyes) and biological objects (e.g., microbes, viruses
and biological cells). The ability to be involved in
photogeneration of active radicals (singlet oxygen and
others) belongs to the family of unique properties of
functionalized fullerenes, which ensures stable interest
in these materials and novel fullerene-based applica-
tions.387
The use of metallofullerenes as catalysts helps to
promote different organic reactions: cycloadditions,
Bingel reactions, Prato reactions, and Diels – Alder
type cycloadditions. The electronic properties of metal-
lofullerenes can also be used to control the catalytic
activity of proteins in vivo. Metallofullerenes have also
been suggested as alternative catalysts with ultralow Pt
loading for PEM fuel cells.
Fullerenol bearing OH groups is successfully used as
a hydrogen-bond catalyst for different reactions (Henry
reaction, aldol reaction, Michael addition reaction,
Friedel – Crafts reaction, etc.) because the high electron
affinity of the C60 cage makes the surface hydroxyl
group a better hydrogen bond donor.
Sensors based on fullerene derivatives are a new field
of application of these carbon materials. The main
direction of the sensoric application is biomedicine.
The possibilities to create hemosensors for identification
or capture of biological objects using fullerene deriva-
tives were demonstrated.
Stimuli-responsive polymer actuators provide large
deformation under the action of an external field (typ-
ically, electric field). Fullerenols can be utilized as fillers
of polymer matrices for actuators because (i) fullerene
molecules allow one to improve the electrical properties
A.V.Penkova, S.F.A.Acquah, L.B.Piotrovskiy, D.A.Markelov, A.S.Semisalova, H.W.Kroto
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of the polymer matrix for large actuation under low
voltage and (ii) the good solubility of fullerenol in water
is necessary for actuator systems.
The main goal of using fullerene derivatives in
optical limiters and optoelectronic devices is to improve
the dispersion of fullerene in polymer matrices in order
to obtain nonlinear optical-limiting and organic semi-
conductor materials. In this context, the most effective
carbon filler is methanofullerene which is highly com-
patible with polymers; however, fullerenols can also be
used. Fullerene derivatives facilitate the dispersion of
fullerenes in polymer matrices. Moreover, the functional
groups of fullerene derivatives can be used as modifiers
or as cross-linking agents in polymer systems.
Modification of polymers with fullerene derivatives
in membrane processes helps to prepare membrane
materials with specified transport properties since tar-
geted changes in the membrane morphology, polymer
structure and free volume can be done with ease.
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